












EXPLORING THE RELATIONSHIP BETWEEN 
TOXIN AND SPORE PRODUCTION IN THE 









































EXPLORING THE RELATIONSHIP BETWEEN 
TOXIN AND SPORE PRODUCTION IN THE 




SARA DE CASTRO GONÇALVES RAMALHETE 
 
 




Supervisor: Prof. Dr. Adriano O. Henriques 
Co-supervisor: Dr. Mónica Serrano 
 
Experimental work performed at the Instituto de Tecnologia Química e Biológica António 












Bibliographic elements resulting from this dissertation 
 
Oral papers: 
Carolina P. Cassona, Sara Ramalhete, Wilson Antunes, Bruno Dupuy, Mónica Serrano 
and Adriano O. Henriques. June 2015. The link between toxinogenesis and sporulation 
during infection by the human intestinal pathogen Clostridium difficile. 17TH European 
workshop on bacterial protein toxins. Braga, Portugal. 
 
Carolina P. Cassona, Sara Ramalhete, Wilson Antunes, Bruno Dupuy, Mónica Serrano 
and Adriano O. Henriques. September 2015. The link between toxin production and spore 
formation in the intestinal pathogen Clostridium difficile. Clostpath 2015 – 9TH 




Carolina P. Cassona, Sara Ramalhete, Wilson Antunes, Bruno Dupuy, Mónica Serrano 
and Adriano O. Henriques. October 2015. The link between toxinogenesis and 
sporulation during infection by the human intestinal pathogen Clostridium difficile. 1º 






First, I would like to thank Prof. Dr. Adriano O. Henriques and Dr. Mónica Serrano 
for the opportunity to work in the laboratory and for the guidance they provided me every 
time that I needed. They were always available to discuss ideas and to give me 
constructive criticisms, which were crucial for me to learn and think outside the box. 
I also would like to thank Carolina Cassona, a very hard worker PhD student that was 
always ready to help and to dispense some of her time to teach me new techniques, and 
to all of the MDL colleagues, Aristides Mendes, Carolina Feliciano, Hugo Barreto, Inês 
Portinha, João Bota, Patrícia Amaral and Wilson Antunes, which were very important to 
turn the team work into funny and pleasant moments. Also, to Teresa Silva for all the help 
in routinary tasks which were crucial for me to save some time. 
I would like to thank the Scientific Committee of the MSc in Medical Microbiology 
of UNL for the organization of this master’s course and to Instituto de Tecnologia 
Química e Biológica António Xavier of Universidade Nova de Lisboa for receiving me as 
a master student during this year. 
Moreover, I would like to thank my family, Rui Ramalhete, Manuela Ramalhete and 
Rui Miguel Ramalhete, for the constant support they gave me to proceed my dreams and 
reach success. To David Braz, which was always ready to give me comfort words that 
were pivotal for me to be the best that I could and for all the good moments that turned 
this journey even happier.  
Finally, to all of my friends which are also family and helped me to relax and create 






Clostridium difficile is currently the major cause of antibiotic-associated 
gastrointestinal diseases in adults. This is a Gram-positive bacterium, endospore-forming 
and an obligate anaerobe that colonizes the gastrointestinal tract. 
Recent years have seen a rise in C. difficile associated disease (CDAD) cases, 
associated with more severe disease symptoms, higher rates of morbidity, mortality and 
recurrence, which were mostly caused due to the emergence of “hypervirulent” strains 
but also due to changing patterns of antibiotics use. C. difficile produces two potent toxins, 
TcdA and TcdB, which are the main virulence factors and the responsible for the disease 
symptoms. These are codified from a Pathogenicity Locus (PaLoc), composed also by the 
positive regulator, TcdR, the holin-like protein, TcdE, and a negative regulator, TcdC. 
Besides the toxins, the oxygen-resistant spores are also essential for transmission of the 
organism through diarrhea; moreover, spores can accumulate in the environment or in the 
host, which will cause disease recurrence. 
The expression of the PaLoc genes occurs in vegetative cells, at the end of the 
exponential growth phase, and in sporulating cells. In this work, we constructed two in-
frame deletion mutants of tcdR and tcdE. We showed that the positive auto regulation of 
tcdR is not significant. However, tcdR is always necessary for the expression of the PaLoc 
genes. 
A previous work showed that, except tcdC, all the PaLoc genes are expressed in the 
forespore. Here, we detected TcdA at the spore surface. Furthermore, we showed that the 
in-frame deletion of tcdE does not affect the accumulation of TcdA in the culture medium 
or in association with cells or spores. This data was important for us to conclude about 
the infeccious process: it suggests that the spore may be the vehicle for the delivery of 
TcdA in early stages of infection, that TcdA may be released during spores germination 








    
 
Resumo  
Clostridium difficile é presentemente a principal causa de doença gastrointestinal 
associada à utilização de antibióticos em adultos. C. difficile é uma bactéria Gram-
positiva, obrigatoriamente anaeróbica, capaz de formar endósporos. Tem-se verificado 
um aumento dos casos de doença associada a C. difficile com sintomas mais severos, 
elevadas taxas de morbilidade, mortalidade e recorrência, em parte, devido à emergência 
de estirpes mais virulentas, mas também devido à má gestão do uso de antibióticos. C. 
difficile produz duas toxinas, TcdA e TcdB, que são os principais fatores de virulência e 
responsáveis pelos sintomas da doença. Estas são codificadas a partir do Locus de 
Patogenicidade (PaLoc) que codifica ainda para um regulador positivo, TcdR, uma 
holina, TcdE, e um regulador negativo, TcdC. Os esporos resistentes ao oxigénio são 
essenciais para a transmissão do organismo e recorrência da doença.  
A expressão dos genes do PaLoc ocorre em células vegetativas, no final da fase de 
crescimento exponencial, e em células em esporulação. Neste trabalho construímos dois 
mutantes de eliminação em fase dos genes tcdR e tcdE. Mostrámos que a auto-regulação 
do gene tcdR não é significativa. No entanto, tcdR é sempre necessário para a expressão 
dos genes presentes no PaLoc.  
Trabalho anterior mostrou que, com a exceção de tcdC, os demais genes do PaLoc são 
expressos no pré-esporo. Mostrámos aqui que TcdA é detectada à superfície do esporo 
maduro e que a eliminação do tcdE não influencia a acumulação de TcdA no meio de 
cultura ou em associação às células ou ao esporo. Estas observações têm consequências 
para o nosso entendimento do processo infecioso: sugerem que o esporo possa ser também 
um veículo para a entrega da toxina nos estágios iniciais da infecção, que TcdA possa ser 
libertada durante a germinação do esporo, e que o esporo possa utilizar o mesmo receptor 
reconhecido por TcdA para a ligação à mucosa do cólon.  
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1. Introduction 
 
1.1. Clostridium difficile  
Clostridium difficile is currently the major cause of antibiotic-associated 
gastrointestinal diseases in adults (Rupnik et al., 2009). C. difficile is a Gram-positive 
bacterium, endospore-forming (hereinafter named spore for simplicity) and an obligate 
anaerobe that colonizes the gastrointestinal tract. C. difficile infection (CDI) occurs when 
the gut microbiota is disrupted (Jernberg et al., 2010; Willing et al., 2011; Pérez-Cobas 
et al., 2013a; Figure 1) and has a range of consequences from asymptomatic carriage to 










Recent years have seen a rise in C. difficile associated disease (CDAD) cases, 
associated with more severe disease symptoms, higher rates of morbidity, mortality and 
recurrence, in part because of the emergence of so called hypervirulent strains, mainly, 
but not exclusively of a specific ribotype, termed 027 (McDonald et al., 2005). Changing 
patterns of antibiotic use have contributed to the problem (McFarland et al., 2007). While 
most CDAD cases affect hospitalized patients under antibiotic treatment, in particular 
clindamycin, aminopenicillins, cephalosporins and fluoroquinolones (Johnson et al., 
1999; Gaynes et al., 2004; Loo et al., 2005; Muto et al., 2005; Pépin et al., 2005), cases 
Figure 1- Development of C. difficile disease. A: Patients are resistant to CDI if their normal microbiota is not 
disrupted by antibiotics; B: Once antibiotic treatment starts, infection with a C. difficile strain that is resistant to the 
antibiotic is more likely; C: When the antibiotic treatment stops, the levels of the antibiotic in the gut diminish rapidly, 
but the microbiota remains disturbed for a variable period of time (indicated by the break in the graph), depending on 
the antibiotic given; D: During this time, patients can be infected with either resistant or susceptible C. difficile. Finally, 
after the microbiota recovers, the resistance to C. difficile is restored (Adapted from Rupnik et al., 2009). 
1 
 
Exploring the relationship between toxin and spore production             S. Ramalhete 
have also been reported without any relation to health care facilities or administration of 
antibiotics prior to the diagnosis (Rupnik et al., 2009). Therefore, CDI is a growing 
concern at the community level, as well as in animal husbandry (Rodriguez-Palacios et 
al., 2006; Songer and Anderson, 2006; Rupnik, 2007). 
C. difficile produces two potent toxins, TcdA and TcdB, which are the main virulence 
factors and the main causes of the disease symptoms (Rupnik et al., 2009; Burns et al., 
2010; Carter et al., 2012; Deakin et al., 2012; Sarker and Paredes-Sabja, 2012).  However, 
the oxygen-resistant spores are essential for transmission of the organism; moreover, 
spores can accumulate in the environment, and in the host, and are responsible for disease 
recurrence (Rupnik et al., 2009; Burns et al., 2010; Carter et al., 2012; Deakin et al., 
2012; Sarker and Paredes-Sabja, 2012). Infection generally begins with the ingestion of 
spores; ingested spores will reach the anaerobic colon and germinate. C. difficile responds 
to unique germinants, such as bile salts (Wilson, 1983). While the bile salt cholate (CA) 
induces spore germination, another primary bile salt, chenodeoxycholate (CDCA) has 
been identified as a potent inhibitor of the process (Sorg and Sonenshein, 2008a and b). 
Upon antibiotic administration, the metabolism of these two compounds is altered and 
the CA concentration in the gut becomes higher than CDCA, triggering spore germination 
(Giel et al., 2010). As the organism propagates, it can produce the TcdA and TcdB 
cytotoxins and more spores (Deneve et al., 2009; Carter et al., 2012). TcdA and TcdB are 
Rho-glucosylating toxins that cause very typical inflammatory lesions in the colon 
epithelium, called pseudomembranes (Just et al., 1995; Thelestam and Chaves-Olarte, 
2000; Jank et al., 2007; Rupnik et al., 2009). Damage of the colonic mucosa eventually 
leads to severe diarrhea, which allows shedding of the spores and transmission to new 
hosts. The treatment recommended by the European Society of Clinical Microbiology 
and Infectious Diseases (ESCMID) is based on the administration of vancomycin, 
metronidazole and the recently introduced fidaxomicin; however, these antibiotics may 
lead to dysbiosis (Debast et al., 2014). Moreover, strains resistant to vancomycin and 
metronidazole have been isolated (Dworczyński et al., 1991; Pelaez et al., 1994). 
The severity of the disease seems linked to the level of dysbiosis (Jernberg et al., 2010; 
Willing et al., 2011; Pérez-Cobas et al., 2013a). While the microbiota may have an overall 
protective role, some species-specific interactions may be important to maintain C. 
difficile in check. A recent study shows that the germination of C. difficile spores is 
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inhibited by C. scindens; this occurs because C. scindens is capable of modifying 
endogenous bile salts which are potent triggers of C. difficile spore germination (Buffie 
et al., 2015). Therefore, and due to the emerging resistant strains, alternative therapies, as 
the faecal microbiota transplantation, are being consider (Matsuoka et al., 2014). 
 
1.2. Sporulation 
Spores are central for the pathogenesis of C. difficile. Spores are highly resistant 
dormant cell types and this resistance is related to their functional architecture. The 
genome is contained within a central compartment delimited by a lipid bilayer with a 
layer of peptidoglycan (PG) (germ cell wall) apposed to its external leaflet; this PG layer 
will serve as the wall of the outgrowing cell that forms when the spore completes 
germination (Henriques and Moran, 2007; de Hoon et al., 2010; McKenney et al., 2012). 
The germ cell wall is surrounded by a modified form of PG, called cortex that is essential 
for the acquisition and maintenance of spore heat resistance (Henriques and Moran, 2007; 
McKenney et al, 2012). In turn, the cortex is enveloped in a multiprotein coat normally 
differentiated into two main layers, an inner and an outer coat. In some organisms, 
including the pathogens B. anthracis, B. cereus and most likely C. difficile, the coat is 
further enclosed within a structure known as the exosporium. The exosporium is formed 
by a basal layer from where projections of glycosylated collagen-like proteins emanate 
(Sylvestre et al., 2002; 2003; Steichen et al., 2003). The coat and exosporium protect the 
spore cortex from the action of PG-breaking enzymes produced by host organisms or 
predators, and confer protection to radiation, UV light and small toxic molecules. In 
addition, the spore surface layers, are required for normal recognition of the molecules 
that signal spore germination and also mediate spore adhesion to cells and abiotic surfaces 
(Henriques and Moran, 2007; Panessa-Warren et al., 2007; Oliva et al., 2009; Paredes-
Sabja et al., 2012; Paredes-Sabja and Sarker, 2012).  
The process of spore differentiation has been extensively studied in the model 
organism B. subtilis but the main morphological stages of sporulation are common to 
other endospore formers that have been studied in some detail (Henriques and Moran, 
2007; de Hoon et al., 2010; McKenney et al., 2012). A hallmark of sporulation is an 
asymmetric (polar) division that divide the rod-shaped cell into a larger mother cell and 
a smaller forespore, the future spore. The mother cell then engulfs the forespore and this 
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process isolates the forespore from the surrounding medium, releasing it as a cell, 
surrounded by a double membrane, within the mother cell cytoplasm (Hilbert and Piggot, 
2004; Higgins and Dworkin, 2012). With the exception of the germ cell wall, which is 
formed from the forespore, the assembly of the main spore protective structures is mostly 
a function of the mother cell (Henriques and Moran, 2007; McKenney et al., 2012). At 
the end of the process, and following a period of spore maturation, the mother cell 














The developmental regulatory network of sporulation shows a hierarchical 
organization and functional logic (de Hoon et al., 2010). A master regulatory protein, 
Spo0A, activated by phosphorylation, governs entry into sporulation, including the switch 
to asymmetric division (Hilbert and Piggot, 2004; Piggot and Hilbert, 2004). Gene 
expression in the forespore and mother cell is controlled by 4 cell type-specific sigma 
factors, which are sequentially activated, alternating between the mother cell and the 
forespore (Figure 2). When Spo0A-P level reaches a critical threshold in B. subtilis, it 
Figure 2 - Morphological stages and compartmentalized gene expression of B. subtilis and C. difficile 
sporulation. In a nutrient rich medium, the cell grows and divides by symmetric division (Predivisional cell, Pd). 
However, upon starvation, the cell enters in sporulation. The process begins with an asymmetric cell division, then, 
the mother cell (Mc) membrane migrates around the forespore (Fs), engulfing it. At the end of this process, the 
forespore becomes a free protoplast in the mother cell cytoplasm. Finally, the cortex (brown) and coat (yellow and 
blue) layers are synthesized and deposited around the developing spore (Sp) and, upon mother cell lysis, a mature 
spore is released to the surrounding environment, where it remains in a dormant state until good germination 
conditions. The compartment of activity of the sporulation σF, σE, σG and σK sigma factors is indicated; their main 
period of activity in C. difficile cells is indicated in red (Pereira et al., 2013).  
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activates sporulation genes including spoIIE as well as both the spoIIAA-spoIIAB-
sigF and the spoIIGA-sigE operons encoding σF and σE, respectively (Molle et al., 2003). 
Regarding the B. subtilis model, σF and σE control the early stages of development in the 
forespore and the mother cell, respectively, and are replaced by σG and σK when 
engulfment of the forespore is completed (Hilbert and Piggot, 2004; Piggot and Hilbert, 
2004; Figure 2). The result is the coordinated deployment of the forespore and mother 
cell lines of gene expression (Hilbert and Piggot, 2004; Piggot and Hilbert, 2004). 
The sporulation pathway of C. difficile and the underlying genetic regulatory network 
have been recently characterized (Fimlaid et at, 2013; Pereira et al., 2013; Saujet et al., 
2013). The main periods of activity of the four cell type-specific sigma factors of C. 
difficile are conserved in comparison with the B. subtilis model (Pereira et al., 2013). 
However, in C. difficile the fact that the activity of σE was partially independent of σF, 
and that σG or σK did not require σE or σG, respectively, seems to imply a weaker 
connection between the forespore and mother cell lines of gene expression (Pereira et al.,  
2013). Relatively to the aerobic Bacilli, the Clostridia represent an older group within the 
Firmicutes phylum, at the base of which endosporulation has emerged some 2.5 billion 
years ago, before the initial rise in oxygen level in the earth atmosphere (Stragier, 2002; 
Paredes et al., 2005; Galperin et al., 2012; Miller et al., 2012; Traag et al., 2012; Abecasis 
et al., 2013). 
 
1.3. Pathogenicity Locus (PaLoc)  
The TcdA and TcdB toxins are encoded by genes located in a Pathogenicity Locus, or 
PaLoc, which carries the genes for three other proteins, TcdR, TcdE and TcdC (Hammond 
and Johnson, 1995, Figure 3). TcdR is an RNA polymerase sigma factor that serves as 
the main positive regulator of expression of the PaLoc (Mani and Dupuy, 2001). TcdE is 
a holin-like protein thought to be involved in toxin secretion (Govind and Dupuy, 2012). 
TcdC is a putative TcdR-specific anti-sigma factor that negatively regulates tcdR-
dependent transcription, at least in vitro (Matamouros et al., 2007; but see below). 
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1.3.1. The positive regulator (TcdR) and the “negative” regulator (TcdC) 
TcdR is an alternative sigma factor with 22 kDa (Moncrief et al., 1997) that positively 
regulates toxin production and also activates its own expression (Mani and Dupuy, 2001). 
This is consistent with the presence of two potential promoters for TcdR-dependent 
transcription in the region upstream of the tcdR gene (Mani et al., 2002). Recently, El 
Meouche and co-workers identified a third potential promoter upstream of tcdR and 
showed that SigD, the main regulatory protein for flagellar biogenesis and motility, 
positively controls toxin gene expression (El Meouche et al., 2013). Under what 
conditions are the tcdR promoters utilized is still unclear.  
Regarding TcdC, this is an acidic, membrane-associated protein with a predicted 
molecular weight of 26 kDa (Braun et al., 1996; Govind et al., 2006), which can form 
dimers (Matamouros et al., 2007). High levels of tcdC transcription may occur during the  
exponential growth phase of C. difficile , concomitant with low transcription of tcdR and 
of the tcdA and tcdB genes, whereas during entry into stationary phase transcription of 
tcdC is low, and transcription of tcdR and the toxin genes is high (Hundsberger et al., 
1997). The reported inverse correlation between the transcription of tcdC and the toxin 
genes and the expression patterns of the corresponding proteins has led to the prevailing 
model that TcdC is an important repressor of toxin expression (Hundsberger et al., 1997). 
This model seems to be supported by the latter finding that the absence of a functional 
TcdC caused by a frame shift mutation (D117 bp) in the tcdC gene is linked to increased 
toxin production in certain “hypervirulent” strains (Warny et al., 2005; Curry et al., 
2007). Importantly, TcdC can bind to TcdR and inhibit TcdR-directed transcription in 
vitro, serving as an anti-sigma factor by destabilizing the TcdR-RNA polymerase core 
enzyme complex (Matamouros et al., 2007).  
Figure 3 - Schematic image of the Pathogenecity Locus (PaLoc). TcdR is a RNA polymerase sigma factor that 
acts as the positive regulator for PaLoc expression; TcdA and TcdB are the cytotoxins, TcdE is a holin-like protein 
and TcdC, a possible anti-TcdR factor (Hammond and Johnson, 1995; Mani and Dupuy, 2001; Matamouros et al., 
2007; Govind and Dupuy, 2012). 
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However, recently, some doubts were raised about the importance of TcdC for 
regulation of toxin expression on the basis of several lines of evidence. First, two studies 
have found increasing levels of tcdC transcription in time that coincide with increasing 
transcription of the toxin genes and increasing amounts of toxin production (Merrigan et 
al., 2010; Vohra and Poxton, 2011). Second, there is a great variability in toxin expression 
levels among “hyperirulent” strains, even though these generally carry mutations in tcdC 
(Curry et al., 2007; Merrigan et al., 2010; Vohra and Poxton, 2011). Third, the prevailing 
model that TcdC is a negative regulator of toxin expression was supported by the finding 
that introduction of a functional tcdC gene into an epidemic strain that carries a non-
functional tcdC gene (M7404, a PCR ribotype NAP1/027 strain) resulted in decreased 
toxin production and attenuated virulence in a hamster model (Carter et al., 2011). 
However, chromosomal complementation in strain R20291, another PCR ribotype 
NAP1/027 strain with an inactive tcdC gene, resulted in no discernible effect on toxin 
expression (Cartman et al., 2012). Moreover, other studies showed that disruption of 
the tcdC gene in the widely used laboratory strain 630Δerm had little if any effect on toxin 
expression under the conditions tested (Bakker et al., 2012; Cartman et al., 2012). Fourth, 
recently, van Leeuwen and co-authors showed that TcdC could bind to DNA folded into 
G-quadruplex structures containing repetitive guanine nucleotides, suggesting that TcdC 
might also act by destabilizing the open complex formation before transcription initiation; 
however, no quadruplex-forming motif with multiple G-stretches was found in the PaLoc 
(van Leeuwen et al., 2013). 
The reasons for the conflicting data may relate to experimental variations, including 
the strain used or the specific growth conditions, either of which might affect the level of 
TcdC expression or activity (Bouillaut et al., 2015). In conclusion, TcdC might have a 
modulatory role in regulating toxin expression, but it is probably not a major determinant 
of the “hypervirulence” of C. difficile (Bakker et al., 2012). 
 
1.3.2. Clostridium difficile cytotoxins 
TcdA and TcdB are single-chain proteins with molecular masses of 308 and 270 kDa, 
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Two infection studies in hamsters attempted to clarify the roles of TcdA and TcdB in 
gastrointestinal disease by using isogenic toxin mutants constructed in the low-virulence 
clinical isolate 630 (Lyras et al., 2009; Kuehne et al., 2010). The first study found that 
TcdB alone resulted in disease (Lyras et al., 2009), while the second concluded that both 
TcdB and TcdA could individually cause severe disease (Kuehne et al., 2010). It is 
interesting to note that a number of clinical cases of C. difficile infection have been 
attributed to naturally occurring A−B+ strains (Drudy et al., 2007; 2007), but that there 
have been no reports of naturally occurring A+B− isolates until now. This would suggest 
that A+B− strains do not exist, but it may also be an artefact of routine diagnostic testing 
practices. Either way, if they do not exist in nature already, they may yet evolve. 
Thus, both TcdA and TcdB seem to have an enterotoxin activity, however, since TcdB 
causes several other symptoms outside the gastrointestinal region (Lanis et al., 2013) and 
has a higher cytopathic potency toward cultured cells (Donta et al., 1982), it is more 
correct to refer this toxin as cytotoxin.  
Both toxins are composed by an N-terminally glucosyltransferase domain followed by 
a cysteine protease domain, a transmembrane domain and a C-terminally receptor binding 
domain which harbours repetitive peptide elements called “combined repetitive 
oligopetides” (CROPs) (Genth et al., 2008). These CROPs exhibit homology to either the 
carbohydrate-binding regions of glycosyltransferases or to domains for the specific 
recognition of choline-containing cell-wall components (Just and Gerhard, 2004). In fact, 
it was shown that TcdA binds to the glycoprotein gp96, a member of the heat shock 
protein family, and that this binding enhances cellular entry of the toxin (Na et al., 2008). 
Regarding TcdB, Michelle E. LaFrance et al. (2015) claim that PVRL3 is one of the 
receptors since they observed a direct binding interaction between PVRL3 and TcdB 
using purified proteins (LaFrancea et al., 2015). Furthermore, they showed that PVRL3 
is independent of the CROPs. This model is compatible with the dual-receptor 
mechanism, proposed by Schorch et al. (2014) where the CROPs domain allows the toxin 
to dock onto the cell surface by interacting with oligosaccharides, followed by toxin 
binding to a high-affinity receptor (Schorch et al., 2014).  
Although there are some potential receptors identified for toxin A and B, further 
studies are required to understand what region(s) of the toxins are binding to what type 
of receptors.  
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Upon receptor binding, the toxin is thought to be internalised into the endosome (Florin 
and Thelestam, 1983). TcdA and TcdB take the “short trip”, which mean they arrange for 
the glucosyltransferase domain to escape from the endosome, instead of the retrograde 
transport through the Golgi apparatus (“long trip”) (Genth et al., 2008). In the 
intermediate part of the delivery domain, a (transmembrane) domain has been postulated 
to be involved in membrane translocation of the glucosyltransferase domain (Just and 
Gerhard, 2004). The pH drop in the acidified endosome is thought to induce a structural 
re-arrangement of the transmembrane domain allowing this domain to form a pore into 
the endosomal membrane (Giesemann et al., 2006). Once the glucosyltransferase domain 
has passed the pore and reached the cytosol, it is proteolytically cleaved off from the rest 
of the protein in the presence of non-proteinaceous cofactors such as inositol phosphates 
(Egerer et al., 2007; Figure 4). It is free to mono-glucosylate and, thereby, inactivate low 
molecular mass GTP-binding proteins of the Rho subfamily (avoiding the GDP-GTP 
exchange) (Herrmann et al., 1998). The Rho subfamilies, which are more probably to be 
affected by these toxins, are: RhoA, Rac1 and Cdc42. This toxicity will compromise the 













Figure 4 - Model of the uptake of C. difficile toxins. Toxins A and B bind to receptors on the surface of target cells 
and are endocytosed. Acidification of the toxins in endosomes exposes hydrophobic regions of the protein allowing 
their insertion into the membrane. At this point, the toxin forms a pore, and the N-terminal catalytic domain is 
translocated from an acidic endosomal compartment into the cytosol. The location of toxin processing is indicated by 
scissors. In the cytosol, the toxins are capable of glycosylating Rho subfamily proteins. The Figure is according to 
Rupnik et al., 2009, with minor modifications. 
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In respect to their role in host–pathogen interactions, Rho proteins essentially 
participate in epithelial barrier functions and cell–cell contact, in immune cell migration, 
phagocytosis, cytokine production, wound repair, immune cell signalling, and superoxide 
anion production (Jank et al., 2007). Rho proteins are regulated by a guanosine 
triphosphatase (GTPase) cycle and they are inactive in the guanosine diphosphate (GDP)-
bound form. Activation occurs after GDP/GTP exchange, which is induced by guanine 
nucleotide exchange factors (GEFs). In the active form, the Rho proteins interact with 
numerous effectors and adaptors (Jank et al., 2007).  
Toxin-catalysed modification of Rho and Ras proteins have several functional 
consequences. Firstly, after glucosylation, Rho/Ras proteins are no longer able to interact 
with their effectors (Herrmann et al., 1998; Sehr et al., 1998). Secondly, glucosylation 
inhibits the activation of small GTPases by GEFs (Herrmann et al., 1998; Sehr et al., 
1998). Finally, glucosylated Rho proteins are associated with the cell membrane and the 
membrane-cytosol cycle is blocked (Genth et al., 1999).  However, the most important 
structural consequence of glucosylation is probably inhibition of the change into the 
active conformation of the GTPase. 
 
1.3.3. The holin-like protein TcdE 
The tcdE open reading frame encodes a small, hydrophobic protein of 166 amino acids 
with a short hydrophilic stretch at the N-terminus, a series of charged residues at the C-
terminus (Tan et al., 2001) and is predicted to contain three transmembrane domains 
(Govind and Dupuy, 2012). These structural features and primary sequence similarities 
strongly suggest that TcdE is a member of the class I holins of which phage λ S protein 
is a member. Holins are small membrane proteins encoded by double-stranded DNA 
phages that are required for the lysis of host cells at a programmed time after completion 
of intracellular phage development (Wang et al., 2000; Young et al., 2000). They form 
disruptive lesions by oligomerization in the host cell plasma membrane to allow a 
prophage-encoded endolysin (a muralytic enzyme) to cross the membrane and attack the 
murein, resulting in cell lysis and release of phage particles (Wang et al., 2000; Young et 
al., 2000). 
Two studies that support this idea are the overexpression of TcdE in Escherichia coli, 
causing cell death (Tan et al., 2001) and the expression of TcdE from its own promoter 
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using a multicopy plasmid, which was lethal to C. difficile (Govind and Dupuy, 2012). 
However, a third study using a controlled expression vector to avoid C. difficile death, 
has shown that when high concentrations of the inducer were added (>50 ng/ml), the 
culture supernatant of the complemented tcdE mutant had a higher concentration of 
toxins than did the parent strain JIR8094 (Govind and Dupuy, 2012). Hence, under 
normal conditions, C. difficile presumably produces an amount of TcdE sufficient to form 
pores that allow release of toxin without causing cell lysis (Govind and Dupuy, 2012). 
Until now, it is not known how these pores interact with toxins. If the toxins are 
secreted unfolded, possibly via translationally coupled secretion, only a narrow channel 
in the cytoplasmic membrane would be needed. Such a channel would not allow 
cytoplasmic protein leakage (Govind and Dupuy, 2012). On the other hand, if the toxins 
are secreted as fully folded proteins, a large membrane channel would be needed due to 
the volumes the large toxin proteins would occupy. Although TcdE has the intrinsic 
ability to form pores in the membrane that lead to permeability and cell death, as seen 
in E. coli (Tan et al., 2001), it does not normally do so in C. difficile (Govind and Dupuy, 
2012). If TcdE-dependent pores are formed in C. difficile, they should be tightly regulated 
by a mechanism that could include the toxins themselves. The toxins could, for instance, 
act as plugs to prevent loss of solutes or proteins from the cells through the TcdE pore. 
Such a model is consistent with the observation that a tcdA tcdB double mutant lysed 
more rapidly than the parental and PaLoc negative strains (Govind and Dupuy, 2012). 
Finally, TcdE-dependent channels might be formed in association with other proteins 
that control the opening of the pore or TcdE could form a specific gated channel that only 
opens in the presence of TcdA/TcdB, without inducing cell lysis (Govind and Dupuy, 
2012).  
Another study showed that the inactivation of tcdE in the low-virulence strain 
630Δerm, did not significantly alter neither the kinetics of release nor the absolute level 
of secreted TcdA and TcdB (Olling et al., 2012). Thus, the impact of TcdE in toxin 
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1.4. Other PaLoc regulators 
The spectrum of diseases caused by C. difficile is highly variable and depends on the 
level of toxin produced (Akerlund et al., 2006). This supports the hypothesis that 
regulation of toxin synthesis is a critical determinant of C. difficile pathogenicity. Toxin 
synthesis increases as cells enter into stationary phase (Hundsberger et al., 1997), and 
many environmental factors influence their production. In the presence of 
phosphotransferase system (PTS) sugars, such as glucose, and of certain aminoacids, like 
cysteine or proline, toxin production is inhibited (Dupuy and Sonenshein, 1998; Karlsson 
et al., 2000). Environmental stresses, such as alteration of the redox potential, exposure 
to sub-inhibitory concentrations of antibiotics, high temperature, or limitation of biotin, 
also modulate toxin production (Onderdonk et al., 1979; Yamakawa et al., 1996; Karlsson 
et al., 2003; Deneve et al., 2009).  
Several regulators are now implicated in toxins synthesis: CodY and Spo0A, two 
regulators that control pre- or post-exponential events, (Dineen et al., 2007; Underwood 
et al., 2009), CcpA, a glucose-dependent repression mediator (Antunes et al., 2011) and 
SigH, a key element in the control of the transition from exponential to the stationary 
phase and of the initiation of sporulation (Saujet et al., 2011). CodY is the first regulator 
encoded outside of the PaLoc that has been shown to participate in the regulation of toxin 
synthesis. Inactivation of the C. difficile codY gene resulted in derepression of all genes 
of the PaLoc during exponential and stationary growth phases, although this repression 
was not so pronounced in tcdC expression (Dineen et al., 2007). Moreover, CodY binds 
to the tcdR promoter region but not to tcdA and tcdB promoters, suggesting that growth 
phase dependent regulation of C. difficile toxin synthesis is mediated by the effect of 
CodY on tcdR transcription (Dineen et al., 2007). This binding was also enhanced in the 
presence of GTP and branched-chain amino acids, thus, regulation by CodY may provide 
a nutritional link to the pathogenicity of C. difficile (Dineen et al., 2007). 
Repression of toxin synthesis in the presence of glucose or other rapidly metabolizable 
carbon sources suggests that the toxin genes are subject to a form of catabolic repression 
(Dupuy and Sonenshein, 1998). In low G+C Gram-positive bacteria, carbon catabolite 
repression (CCR) is mediated by CcpA. To test this correlation, crude extracts of the 
parental strain were obtained from cells collected during stationary phase (14 h) and the 
total toxin levels were assayed by Vero cell cytotoxicity assays. In cells grown in the 
12 
 
Exploring the relationship between toxin and spore production             S. Ramalhete 
presence of glucose, the cytotoxic activity was low as compared with that of cells grown 
without glucose. Moreover, using specific antibodies against TcdA, researchers also 
showed by Western blot that toxin A accumulation was strongly repressed in the presence 
of glucose (Antunes et al., 2011). Moreover, the cytotoxic activity and the quantity of 
TcdA detected in crude extracts of the ccpA mutant grown in the absence or in presence 
of glucose were the same, which indicates that CcpA mediates glucose repression of toxin 
synthesis (Antunes et al., 2011). Furthermore, the same study showed that the effect of 
CcpA is direct since this regulator interacts with the tcdB promoter region and the 5′ end 
of the tcdA-coding sequence (Antunes et al., 2011).  
Taking this into consideration, CodY and CcpA act by monitoring the nutrient 
sufficiency of the environment, directly repressing the PaLoc genes, and releasing this 
repression during stationary phase, when nutrient condition become limited (Dineen et 
al., 2007; Antunes et al., 2011). 
Regarding Spo0A, this protein is conserved in all spore-forming bacteria, essential in 
the initiation of the developmental pathway of spore formation, and was also reported to 
be a PaLoc repressor (Zhao et al., 2002; Underwood et al., 2009). However, recent studies 
have failed to elucidate the role of Spo0A in TcdA and TcdB production by C. difficile, 
with conflicting data published to date (Underwood et al., 2009; Deakin et al., 2012; 
Rosenbusch et al., 2012; Mackin et al., 2013). In “hypervirulent” strains, as R20291, 
Spo0A acts as a negative regulator of TcdA and TcdB production (Deakin et al., 2012). 
In contrast, Spo0A does not appear to regulate toxin production in the low-virulence strain 
630Δerm (Rosenbusch et al., 2012). Moreover, in other strains (as JGS6133), Spo0A 
appears to negatively regulate toxin production during early stationary phase, but has little 
effect on toxin expression during late stationary phase (Mackin et al., 2013). These data 
suggest that Spo0A may differentially regulate toxin production in distinct C. difficile 
strain types. In any case, as no Spo0A boxes are present upstream of the tcdA and tcdB 
genes, an indirect effect of Spo0A on their transcription may happen via a still 
uncharacterized regulator (Underwood et al., 2009). 
Another study established a correlation between the PaLoc components and sigH 
expression in the stationary phase. tcdR, tcdB and tcdA showed increased transcription in 
the sigH mutant than in the 630Δerm strain, while in the sigH complemented strain, the 
expression was restored to the level observed in 630Δerm strain for all the three genes. 
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Therefore, the expression of these three genes is negatively controlled by σH (Saujet et 
al., 2011). However, no σH consensus sequences are present in the PaLoc, suggesting an 
indirect effect of σH in the inhibition of the PaLoc transcription. Because the expression 
of tcdC was similar in the 630Δerm strain and in the sigH mutant, authors suggested that 
the absence of modulation of tcdC transcription in the sigH mutant indicates that the σH-
dependent control of tcdA, tcdB, and tcdR expression is not mediated by the regulation of 
TcdC synthesis (Saujet et al., 2011). However, they could not exclude the possibility that 
σH may influence factors controlling TcdC stability and/or activity (Saujet et al., 2011). 
In conclusion, there are four negative regulators encoded outside the PaLoc that 
participate in the regulation of toxin production. These are some examples of the possible 
PaLoc regulators, which indicates us that the toxins production is a process that needs to 
be extremely well controlled, since these are the major virulence factors of C. difficile. 
 
1.5. Genetic tools and single-cell analysis of the PaLoc expression 
Although a very important pathogen, only recently a solid platform of genetic and cell 
biology tools was developed for C. difficile. Studies to understand in more detail C. 
difficile colonization, virulence and pathogenesis are now possible. First, directed mutants 
could only be made using insertional mutagens, reliant either on replication deficient 
(Liyanage et al., 2001) or defective (O’Connor et al., 2006; Dineen et al., 2007) plasmids, 
or on the deployment of the ClosTron and group II intron re-targeting (Heap et al., 2007; 
Heap et al., 2010). Recently, the cytosine deaminase gene (codA) of E. coli was developed 
as a negative/counter selection marker for C. difficile, which enabled precise 
manipulation of the C. difficile chromosome for the first time (Cartman et al., 2012). In 
parallel, a second method (Allele-Coupled Exchange, ACE) has been formulated that 
allows the rapid insertion of heterologous DNA, of any size or complexity, into the 
genome (Heap et al., 2012). Because the ACE mutagenesis system allows a specific in-
frame deletion, which reduces the polar effects, this was the chosen system for this work. 
In other hand, the autofluorescence proteins (AFP’s) that have enable noninvasive 
imaging in living cells of reporter gene expression and therefore have become 
indispensible tools in cell and development biology, cannot be applied in strict anaerobes 
like C. difficile. Recently, our laboratory has implemented a system based on a mutant 
form of the human DNA repair enzyme O6-alkylguanine-DNA alkyltransferase 
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(SNAPCd-tag) (Pereira et al., 2013) to examine gene expression in single cells of C. 
difficile (Figure 5). The SNAPCd-tag reacts with benzyl purine or pyrimidine substrates 
that can be coupled to different fluorescent molecules (TMR-star which is commercially 









Although a wealth of literature has addressed the process of toxinogenesis in C. 
difficile, expression of the tcdA and tcdB genes, and indeed of the other three PaLoc genes, 
was never studied at the single-cell level. This kind of study is very important given the 
increase evidence that exist cell-to-cell differences at the gene expression level in 
bacterial populations. Such gene expression heterogeneity determines the fate of 
individual cell and can also ultimate the fate of the population as a whole.  
In preliminary work made in the laboratory we have fused the tcdR, tcdB, tcdE, tcdA 
and tcdC promoters (all the regulatory regions of the PaLoc genes) to the SNAPCd-tag 
and assessed gene expression in a medium that support toxin production in the standard 
laboratory strain 630Δerm (Figure 6). Two cellular populations expressing tcdR during 
stationary phase were observed, a smaller one consisted of cells without signs of 
asymmetric division; a larger one consisted of sporulating cells in which, strikingly, tcdR 
is expressed in the forespore (Figure 6B). As expected, fluorescence was not detected 
during exponential growth (data not shown). These results already show that the PaLoc 
expression is spatially and temporally regulated. Since we found tcdR to be expressed in 
the forespore, we therefore anticipated accumulation of the toxin in the developing spore. 
Figure 5 - The SNAPCd technology extended to C. difficile. A: Schematic representation of SNAPCd labelling. C. 
difficile cells carry a replicative plasmid where the SNAPCd sequence is under the control or fused to a gene of interest. 
These cells are cultivated under appropriate conditions that allow production of the SNAPCd protein, time at which a 
cell permeable label (red) should be added. The permeable label enters into the cell, where a covalent modification 
occurs, allowing labelling and visualization of the SNAPCd protein by fluorescence. B: Microscopy analysis of C. 
difficile cells producing SNAPCd visualized by the red color after labelling with the TMR-Star cell-permeable SNAPCd 
substrate (Pereira et al., 2013). 
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tcdB and tcdE have similar patterns of expression to tcdR. tcdA is also expressed in two 
populations during stationary phase, in cells without signs of asymmetric division and 
also in sporulating cells, both in the mother cell and in the forespore (Figure 6).  
In contrast, tcdC expression was detected during exponential growth (data not shown). 
During stationary phase, tcdC is also expressed in either cells without signs of 
asymmetric division or in the mother cell during sporulation.  However, expression of 
tcdC was never detected in the forespore.   
Given these results, it is pertinent to go depth in the study of the cell population 





Figure 6 - Fluorescence microscopy using SNAPCd-tag fused to different promoters of the PaLoc components 
(tcdR, tcdB, tcdE, tcdA and tcdC). A: Regulatory interactions in the Pathogenicity Locus. TcdR is thought to be auto-
regulatory; TcdR also activates transcription from the indicated PaLoc promoters; B: Cells were incubated 24h in TY 
medium and observed by fluorescence microscopy. The green color corresponds to C. difficile autofluorescence while 
the red one corresponds to the reaction of the SNAPCd reporter with the TMR-Star substrate. tcdR expression is mainly 
detected in the forespore, as is that of tcdB. The expression of tcdA appears mostly in vegetative and mother cells but 
also in some forespores. tcdC expression seems to be excluded from the forespore. Finally, tcdE was mainly expressed 
in the forespore. Scale bar: 1µm; C: Percentages of each of the following cell classes: vegetative cells with little 
expression (light red) and high expression (red) and sporangia with whole cell expression or only in the forespore. 
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1.6. Objectives of the work 
The preliminary results described above show that sporulation and toxinogenesis are 
interconnected, with expression of the PaLoc genes during sporulation. To increase our 
knowledge on the relationship between toxinogenesis and sporogenesis, we focused our 
attention on the regulation of tcdR expression and on the role of tcdE on TcdA secretion 
and localization. Our specific aims were: 
1. To construct a tcdR mutant, and to study the impact of this mutation on tcdA and 
tcdR expression, on growth and on sporulation. Since tcdR expression was detected 
in the forespore, we followed this clue to study the relationship between sporulation 
and toxin production. Furthermore, this mutant was crucial to understand the 
relevance of the tcdR positive feedback and to confirm tcdA regulation by TcdR.  
2. To analyze the accumulation and localization of TcdA in the mature spore, since 
expression of tcdA was detected in both the mother cells and in the forespore.  
3. To construct a tcdE mutant, and to study the impact of the mutation on toxin 
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2.  Material and methods 
 
2.1. Microbiological techniques 
 
2.1.1. Bacterial strains and growth conditions 
Escherichia coli strain DH5α was used as a host for molecular cloning and for plasmid 
propagation (Appendix 1); E. coli strain HB101 was used for conjugation of plasmids 
into C. difficile due to the presence of the conjugational plasmid RP4. Luria Bertani (LB) 
medium (1% tryptone, 0.5% yeast extract, 0.5% NaCl, pH 7.0) was routinely used for 
growth and maintenance of E. coli. When necessary, agar (Agar nº2 bacteriological, from 
LAB M) was added to a final concentration of 1.6%. When appropriate, ampicillin (100 
µg/mL) or chloramphenicol (20 µg/mL) was added to the culture medium. 
All the strains of C. difficile used in this work are congenic with 630Δerm (Hussain et 
al., 2005), the reference strain in the field, and are listed in Appendix 2. Strain 630Δerm 
is hereinafter referred to as the wild type (WT) for simplicity and belongs to the ribotype 
012, which is not classified as “hypervirulent”. All strains were stored at -80ºC in 20% 
glycerol. C. difficile strains were routinely grown anaerobically (5% H2, 15% CO2, 80% 
N2) at 37ºC in brain heart infusion (BHI; from Oxoid) or in BHI supplemented with 0.1% 
L-cysteine and 5 mg/ml yeast extract (BHIS). Bacto agar (from BD) was normally used 
at a final concentration of 1.6%. A C. difficile minimal medium (CDMM; Karasawa et 
al., 1995) solidified with 1.5% agar (from BD) was required for the ACE mutagenesis 
(see below; Appendix 3). CDMM was supplemented with 5-fluoroorotic acid (2 mg/ml) 
and uracil (5 µg/ml) when appropriate. For some experiments, C. difficile was grown in 
Tryptone Yeast Extract medium (TY: 3% bacto tryptone, 2% bacto yeast extract). When 
necessary, cefoxitin (25 µg/ml) and thiamphenicol (15 µg/ml) were added to C. difficile 
cultures. For tcdE complementation anhydrotetracycline (ATc) was used at a 
concentration of 20 ng/ml.  
Sporulation assays were performed in Sporulation Medium (SM): 9% bacto tryptone, 
0.5% bacto peptone, 1% (NH4)2SO4 and 0.15% Tris base, pH 7.4 (Wilson et al., 1982). 
The pre-inoculumn was inoculated in SM medium (1:200 dilution) and, after 24, 48 and 
72 hours the sporulation efficiency was analysed. Serial dilutions were performed (up to 
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10-6) and three spots (20 µl) of each of the 10-6, 10-5, 10-4 and 10-3 dilutions were spotted 
onto BHI plates containing 0.1% taurocholate acid sodium salt (from Roth) to induce 
spore germination. The 10-1, 10-2, 10-3 and 10-4 diluted cultures were removed from the 
chamber and incubated 30 minutes at 60°C to kill vegetative cells. Finally, these were 
introduced again inside the chamber and three spots of 20 µl were spotted onto a BHI 
plate containing 0.1% taurocholate. All plates were incubated overnight under anaerobic 
conditions. The colonies counting was concluded after 24h of the plates inoculation and 








Dilution – Dilution factor (e. g., 10-2, 10-3). 
Volume – Plated volume in ml. 
 
For spore production, C. difficile was grown in BHI. An overnight culture was added 
to BHI liquid medium in a T-flask with a final dilution of 1:100. Cultures were incubated 
anaerobically in the horizontal for 7 days at 37ºC. Cells were collected by centrifugation 
at 4700 x g, resuspended in cold water and stored over 48h at 4ºC, for lysis of mother 
cells and release of the spores. The suspension was centrifuged again for 10 minutes at 
4700 x g, 4ºC and the sediment was suspended in 1 ml of 1x PBS (137 mM NaCl, 2.7 
mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.6) 0.1% tween 20 (PBS-T). This 
suspension was applied on top of 25 ml of a 42% Gastrografin solution (from Bayer) and 
centrifuged for 20 minutes at 4700 x g, 4ºC. The supernatant was then aspirated using a 
vacuum apparatus and the sediment suspended again in 1 ml of PBS-T. Two more washes 
in PBS-T were performed (to remove traces of Gastrografin) at 4700 x g during 3 minutes 
at room temperature. Lastly, the sediment was washed two times in water and, finally, 
suspended in 500 μl of water.  
 
2.1.2.  Bacterial growth  
Cultures were incubated under anaerobic conditions and growth was followed by 
measuring the optical density at 600 nm (OD600) at hourly intervals. The growth rate was 
calculated from the slope of the part of the curve that corresponds to the exponential 
growth phase, while the generation time was determined according to the following 
equation: generation time = ln(2)/growth rate. 
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2.2. Biochemical techniques 
 
2.2.1.  Spore fractionation 
The volume of a purified spore suspension used in fractionation experiments was 
determined by measure of spore suspension OD580, previously diluted 1:200 in bi-distiled 
water (ddH2O), and using the following formula: 
Volume of suspension (µl) = (3600/OD580) x 200 
 
The spores were resuspended in 50 µl of 2X decoating buffer (10% glycerol, 4% SDS, 
10% β-mercaptoethanol, 1 mM DTT, 250 mM Tris, pH 6.8). Samples were boiled for 5 
minutes and centrifuged 2 minutes at 16200 x g. Finally, supernatants were collected to a 
new tube and 2 µl of 1% bromophenol blue were added. 25 µl of the samples were applied 
on a 12.5% SDS-PAGE gel (12.5% resolving gel: 41% distilled water, 25.4% 4x lower 
Tris buffer, 12.6% bis-acrylamide, 0.1% SDS, 0.1% ammonium peroxydisulphate, 0.05% 
tetramethylethylenediamine, these last two induced polymerization; 4.5% stacking gel: 
61.2% distilled water, 25.5% 4x upper Tris buffer, 10.2% bis-acrylamide, 0.1% SDS, 
0.1% ammonium peroxydisulphate, 0.1% tetramethylethylenediamine). 
The sediments resulting from the spore decoating step were washed twice in PBS-T. 
Sediments were suspended in 100 µl of PBS-T and divided in two tubes. These were 
centrifuged 3 minutes at 4700 x g and one of the two sediments was suspended in 25 µl 
of 50 mM Tris HCl, pH 8.0 with 2 mg/ml lysozyme, while the other was suspended in 25 
µl of 50 mM Tris HCl, pH 8.0. Samples were incubated at 37°C for 2 hours and, after this 
time, 25 µl of loading buffer 2X (0.125 mM Tris-HCl, 5% β-mercaptoethanol, 2% SDS, 
0.025% bromophenol blue, 0.5% mM DTT, 5% glycerol, pH 6.8) were added. For each 
of the samples, 50 µl were resolved by SDS-PAGE gel (12.5% gels). The Precision Plus 
Protein™ All Blue Ladder (from BioRad) was used in each run. 
The resulting gel was incubated 1 hour in the coomassie solution (0.5 g/ml coomassie 
Brilliant Blue R-250, 80% absolut ethanol, 20% acetic acid) and then, incubated in 
destaining solution (30% absolut ethanol, 10% acetic acid) overnight with agitation at 
room temperature. In the next day, the gel was incubated with new destaining solution 
until the background was clear.  
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2.2.2.  Western blot 
Proteins were electrophoretically transferred from SDS-PAGE gel to nitrocellulose 
membranes (Supported Nitrocellulose, 0.45 µm; from BioRad) at 100 V for 90 minutes 
using transfer buffer (14.4 g/L glycine, 3.02 g/L Tris base, 10% ETOH). The membrane 
was incubated in 20 ml of blocking solution (5% milk in PBS-T) for 1 hour with agitation. 
Next, the blocking solution was removed and the antibody solution was added in 10 ml 
of PBS-T with 0.5% milk [An anti-TcdA antibody (from Santa Cruz Biotechnology) was 
used at a dilution of 1:5000; an anti-CotD antibody (Permpoonpattana et al., 2011) was 
used at a dilution of 1:1000 and an anti-CotA antibody (Permpoonpattana et al., 2011) 
was used at a dilution of 1:3000]. The membrane was incubated overnight with the 
antibody solution at 4°C without agitation. The antibody solution was then discarded and 
the membrane was washed 3 times in PBS-T (10 minutes each wash). The secondary 
antibody (mouse peroxidase-conjugated secondary antibody from Sigma) was then added 
in 10 ml of PBS-T with 0.5% milk at a dilution of 1:2000. The membrane was incubated 
30 minutes at room temperature with agitation. Finally, the membrane was washed 3 more 
times in PBS-T (10 minutes each) and the protein was detected using the detection 
solution (“SuperSignal West Pico Chemiluminescent” from Thermo Scientific) in the 
dark.  
For reprobing, membranes were incubated in 20 ml of a stripping solution (6.25% Tris-
HCl pH 6.8, 2% SDS, 0.7% 2-mercaptoethanol) for 30 minutes at 50ºC (with agitation 
every 10 minutes). Then, the membrane was washed in distilled running water and 
incubated in blocking solution. The remaining of the protocol is the same as described 
above. 
 
2.2.3.  Dot blot 
This technique represents a simplification of the western blot method. In a dot blot, 
the biomolecules are not separated by electrophoresis as the western blot requires. 
Instead, a mixture containing the molecule which we want to detect is applied directly on 
a membrane as a dot. This is then followed by antibody detection (see above 2.2.2).  
C. difficile cultures were centrifuged and two fractions were obtained, the sediment 
and the supernatant. 10 ml of the supernatant was concentrated up to 1 ml in an Amicon 
Ultra-4 Centrifugal Filter Unit with Ultracel-50 membrane and 200 µl of the concentrated 
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solution were analysed by dot blot, except when the total amount of proteins were 
normalized (see 2.2.4), in this case, different volumes of each sample were used. The 
sediment resulting from the centrifugation was suspended in 1 ml of French press buffer 
(10 mM Tris pH 8.0, 10 mM MgCl2, 0.5 mM EDTA, 0.2 mM NaCl, 10% glycerol, 1 mM 
PMSF) and cells were lysed at 900 psi. 1 µl of DNAse was added to this extract which 
was then clarified by centrifugation for 10 minutes at 16200 x g, 4ºC. 20 µl of the 
supernatant were analysed by dot blot, except when the total amount of proteins were 
normalized (see 2.2.4).  
 
2.2.4. Bradford protein assay 
This is a spectroscopic analytical procedure used to measure the protein concentration 
in a solution. The protein assay-dye (from BioRad) was diluted 5x in ddH2O. For the 
reference, 200 µl of this diluted solution were added to 800 µl of ddH2O. In order to 
measure the protein concentration, 10 µl of each sample were added to 200 µl of the 
diluted Bradford solution and 790 µl of ddH2O. The absorbance (A) of the mixture was 








2.3. Genetics and molecular biology techniques 
 
2.3.1.  Molecular cloning 
DNA fragments for cloning were generated by the polymerase chain reaction (PCR) 
using the high fidelity Phusion DNA polymerase (from Thermo Fisher Scientific).  All 
oligonucleotide primers used in this work are listed in Appendix 4. PCR products were 
purified and concentrated using the DNA Clean and ConcentratorTM – 5 kit (from Zymo 
research). General cloning methodologies were as previously described (Sambrook and 
Green, 2012). All DNA restriction and modification enzymes were obtained from Thermo 
Fisher Scientific and used according to the manufacturer's guidelines. All the plasmids 
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used and constructed during this work are listed in Appendix 5. The sequence of all newly 
constructed plasmids was verified by DNA sequencing. 
 
2.3.2.  Gel electrophoresis of nucleic acids 
In order to verify the presence of specific DNA fragments, samples were subjected to 
1% agarose gels in TAE 1X (50X: 242 g/L Tris base, 5.71% glacial acetic acid, 10% 0.5 
M EDTA, pH 8.0) buffer. Before application in the gel, orange G loading buffer (2.5% 
ficoll-400, 11 mM EDTA, 3.3 mM Tris-HCl, 0.017% SDS, 0.15% orange G, pH 8.0) was 
added to the sample. These gels run in the presence of ethidium bromide [0.001% (v/v)] 
at 110 Volts. The DNA was visualized using UV light (205 nm). The size of the fragments 
was measured by comparison with commercial molecular weight marker 1 Kilo base pair 
(Kb) Plus DNA Ladder (from Invitrogen). 
 
2.3.3.  Preparation of E. coli competent cells and transformation 
In order to cells have the ability to uptake extracellular DNA from the environment, 
they need to be competent. However, when it does not occur naturally in some bacteria, 
as E. coli, it can be induced. To achieve that, fresh LB medium (100 ml) was inoculated 
with 200 µl of an overnight E. coli culture and incubated at 37°C to an OD550nm ~ 0.3-0.4. 
This culture was placed on ice for 15 minutes and centrifuged at 900 x g for 15 minutes 
at 4°C. Then, the supernatant was removed and the sediment was resuspended in ice-cold 
RF1 buffer, pH 5.8 (12 mg/ml RbCl, 9.9 mg/ml MnCl2, 1.5 mg/ml CaCl2, 11% glycerol, 
3% KAc 1M pH 7.46) by pipetting gently up and down (30 ml per 100 ml of culture). 
After a 15 minutes incubation on ice, the tube was, again, centrifuged at 900 x g for 15 
minutes at 4°C and the supernatant was removed. Then, the sediment was resuspended in 
8 ml of ice-cold RF2 buffer, pH 6.8. (1.2 mg/ml RbCl, 8.3 mg/ml CaCl2, 10% glycerol, 
2% MOPS 0.5 M, pH 6.8).   
The transformation process happens when a cell incorporates exogenous 
genetic material from the surroundings. First, cells need to contact with the plasmid, 
therefore, 10 µl of the ligation mixture were added to 200 µl of competent E. coli cells 
followed by a 40 minutes incubation on ice. A thermal shock was performed during 90 
seconds at 42°C and then 2 minutes on ice. 
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After cells recover in 1 ml of LB at 37°C for two hours, the tube was centrifuged 5 
minutes at 3500 x g. 1 ml of the supernatant was discarded and the sediment was 
resuspended in the remaining volume. All of this content was plated in LA with the 
appropriate antibiotics and incubated overnight at 37°C. 
 
2.3.4.  Extraction of plasmid DNA 
In order to detect the transformant colony carrying the plasmid of interest, minipreps 
were performed to extract the plasmid DNA. The verification of the insert was done using 
restriction enzymes that digest not only the vector but also the insert.  
An isolated colony resulting from E. coli DH5α transformation was incubated 
overnight in 5 ml of LB with the appropriate antibiotic. 2 ml of this culture were 
centrifuged 5 minutes at 16200 x g and the sediment was resuspended in 394 µl of a 
solution containing 360 µl of STET buffer (8% sucrose, 0.5% Triton X-100 (v/v), 50 mM 
EDTA, 10 mM Tris-HCl, pH 8.0), 24 µl of lysozyme (10 mg/ml) and 10 µl of RNAse (10 
mg/ml). The tube was incubated at 37ºC for 30 minutes and after that, it was boiled for 1 
minute. Then, it was centrifuged at 16200 x g for 5 minutes and the sediment was removed 
with a loop. Isopropanol was added to the remaining content at a final concentration of 
70% (v/v) and the tube was, again, centrifuged at 16200 x g for 45 minutes at 4ºC. Finally, 
the supernatant was carefully decanted, the sediment was air dried and 20 µl of ddH2O 
were added to suspend the sediment. 
When the goal was to extract the plasmid to transform HB101 cells and to confirm the 
DNA sequence by sequencing, the “ZR-plasmid Minipreps kit classic” (from Zymo 
research) was used, since the efficiency of this technique is much higher than the one 
presented above. This method is based on the alkaline lysis of cells and adsorption of 
DNA to a silica matrix immobilized in a column, which is then eluted.  
 
2.3.5.  C. difficile conjugation 
The conjugation process is another DNA transference method that requires direct cell-
to-cell contact and a bridge-like connection between two cells. Using E. coli HB101 
(pRP4) strain as a donor, the plasmids were transferred by conjugation into C. difficile 
strains as described previously (Purdy et al., 2002). A single colony of E. coli HB101 
with the plasmid of interest was inoculated in 5 ml of LB with the appropriate antibiotics 
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and incubated at 37ºC with agitation, overnight. Also, a single colony of C. difficile 
630ΔermΔpyrE was inoculated in 10 ml of BHIS and incubated overnight (O/N) at 37ºC 
under anaerobic conditions. In the next day, 1 ml of the E. coli culture was centrifuged at 
3000 x g for two minutes and the supernatant was discarded. The sediment was carefully 
washed in 1 ml of LB. E. coli cells were resuspended in 300 µl of C. difficile culture and 
the conjugative mixture was pipetted in 25 µl spots in a BHIS plate. This plate was not 
inverted and it was incubated under anaerobic conditions O/N. In the following day, cells 
were carefully scraped with a loop on the surface of the BHIS plate. This content was 
resuspended in 1 ml of BHIS and 150 µl of the mixture was plated in four BHIS plates 
supplemented with cefoxitin and thiamphenicol to select for strains that successfully 
received the plasmid. The cefoxitin will function as a selection of C. difficile against E. 
coli, while the thiamphenicol will select only cells that have the plasmid. The 400 µl 
leftovers were used to perform a 1:5 dilution and 150 µl of the diluted mixture were plated 
in four BHIS plates. Plates were incubated O/N at 37ºC under anaerobic conditions. 
 
2.3.6.  Allele-Coupled Exchange (ACE) mutagenesis 
In ACE mutagenesis, a specific plasmid originated from pMTL-YN3 containing a 
truncated gene and the flanking regions (to allow recombination), is expected to integrate 
in the chromosome and replace the wild type gene by a truncated version of it. One of the 
requirements for this mutagenesis process is the prior inactivation of a gene which will 
allow a positive and a negative selection (Ng et al., 2013). In this case, the gene is the 
pyrE which encodes an orotate phosphoribosyltransferase, an enzyme involved in de novo 
pyrimidine biosynthesis. This gene is given in trans in the plasmid originated from 
pMTL-YN3 (Ng et al., 2013; Figure 7) that is used for the mutagenesis. It works as a 
positive/negative selection marker as it is essential in the absence of exogenous 
pyrimidines and it also renders 5-fluoroorotic acid (FOA) toxic to cells (Ng et al., 2013). 
Toxicity occurs via a series of steps which result in misincorporation of fluorinated 
nucleotides (5-fluoruracil) into DNA and RNA and hence, cause cell death (Ng et al., 
2013).  
Crucially, having created the interested mutants, a specific ACE-vector (pMTL-YN1; 
Appendix 5) was used to restore the chromosomal pyrE allele back to wild-type, allowing 
the specific in-frame deletion mutant to be characterised in a clean, wild-type background. 
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Also, a variant of the same vector (pMTL-YN1C; Appendix 5) is used to deliver the wild-
type allele of the gene under study, allowing complementation studies. 
An important characteristic is that the plasmids used in ACE mutagenesis are “pseudo-
suicide” vectors, then, they should easily integrate in the chromossome (Cartman et al., 
2010, Cartman et al., 2012). 
The first conjugant colonies (see above section 2.3.5) that had the plasmid containing 
the in-frame deletion of the gene under study, started to appear after two or three days 
and the isolated ones were streaked into BHIS supplemented with cefoxitin and 
thiamphenicol. This step was repeated one more time to select for the single cross-over, 
which means that the plasmid was integrated in the chromosome. After 2 to 3 days, the 
larger colonies were ready for the single cross-over verification. First, a loop was 
necessary to collect the isolated colony and inoculate into a new BHIS plate supplemented 
with cefoxitin and thiamphenicol, also, the same loop was used to resuspend in 5% chelex 
resin (Sigma-Aldrich). After the genomic DNA extraction (see below Chelex protocol in 
2.3.7), the single cross–over was verified by PCR. The positive clone was then transferred 
to C. difficile minimal medium supplemented with FOA (2 mg/ml) and uracil (5 µg/ml). 
Colonies which grew in this medium were rounder and yellow than the usual and they 
took about 2/3 days to show up. The ones that were able to grow were tested for the 
plasmid excision by PCR which mean that the second single cross-over excised the 
plasmid with the pyrE gene and because of that, cells were resistant to the FOA. The 
positive clones were finally tested in BHIS supplemented with cefoxitin and 
thiamphenicol to exclude the presence of the plasmid (which have the thiamphenicol 
resistance mark) in the mutant strain.  
At this point, a strain with deletion for the gene under study in a background ΔpyrE 
was constructed. To revert the pyrE- background, the strain was conjugated with E. coli 
HB101 (pRP4) carrying pMTL-YN1 (containing the pyrE gene; Ng et al., 2013) and the 
conjugant colonies were then transferred into C. difficile minimal medium. The ones 
which grew in this medium, were analysed by PCR to confirm the pyrE reversion. The 
positive clones were finally tested in BHIS supplemented with cefoxitin and 
thiamphenicol to exclude the presence of the plasmid (which have the thiamphenicol 
resistance mark) in the mutant strain. To discard polar effects, trans-complementation 
analysis was conducted. Using E. coli HB101 (pRP4) strain as a donor, the 
27 
 
Exploring the relationship between toxin and spore production             S. Ramalhete 
complementation plasmid originated from pMTL-YN1C (containing the WT gene under 
study in the pyrE locus) was transferred by conjugation into C. difficile 
630ΔermΔpyrEΔtcdR/E carrying the mutation. Conjugant colonies were transferred into 
C. difficile minimal medium and the ones that grew were analysed by PCR to confirm the 
presence of a copy of the interest gene at the pyrE locus. The positive clones were finally 
tested in BHIS supplemented with cefoxitin and thiamphenicol to exclude the presence 
of the plasmid (which bears the thiamphenicol resistance mark) in the mutant strain. 
 
2.3.7.  Genomic DNA extraction  
C. difficile genomic DNA was extracted using the chelex (Sigma-Aldrich) resin that 
binds cellular polar components while the RNA and DNA remain in water solution.  
A single colony was resuspended in 100 µl of 5% chelex resin. Then, cells were 
subjected to a heat shock at 95ºC for 10 minutes followed by a centrifugation at 10000 x 
g for 1 minute. Finally, 50 µl of the supernatant were collected and 1 µl was directly used 
for PCR. 
 
2.4. Cell Biology 
 
2.4.1.  Fluorescence microscopy and image analysis 
For SNAPCd labelling, C. difficile was grown in TY for 24 hours. After this period, 
200 μl of the culture were added to 1 μl of TMR (50 μM) to a final concentration of 250 
nM and the mixture incubated for 30 min in the dark. Following labelling, the cells were 
removed from the anaerobic chamber and collected by centrifugation (3500 x g for 2 
minutes at room temperature), washed 3 times in 1 ml of 1x PBS and, finally, resuspended 
in 10 μl of 1x PBS. Cells (4 μl) were mounted on a 1.7% agarose coated glass slide and 
observed on a Leica DM6000B microscope equipped with a phase contrast Uplan 
F1 100x objective and a CCD IxonEM camera (from Andor Technologies; Serrano et al., 
2011). The images were taken with exposition time of 50 ms for bright field and 1000-
3000 ms for TMR. Images were acquired and analysed using the Metamorph software 
suite version 5.8 (from Universal Imaging), and adjusted and cropped using Photoshop 
CS5. For quantification of the SNAPCd signal resulting from the transcriptional fusions, 
6x6 pixel regions were defined in the desired cell and the average pixel intensity was 
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calculated by the Metamorph software, and corrected by subtracting the average pixel 



















































Exploring the relationship between toxin and spore production             S. Ramalhete 
3. Results 
 
3.1. Construction and in trans complementation of an in-frame deletion mutant 
of tcdR 
TcdR is an RNA polymerase sigma factor that serves as the main positive regulator of 
expression of the PaLoc genes, which is hence under positive auto-regulation (Mani et 
al., 2001; 2002). Although the regulation of the PaLoc by TcdR has been studied in vitro, 
few studies have addressed the impact of a tcdR mutation on expression of the PaLoc 
during growth of C. difficile (Mckee et al., 2013) and none at the single cell level. We 
first constructed a strain carrying an in-frame deletion of tcdR to understand how the 
absence of the protein would have an impact on the expression of the PaLoc genes and, 
since tcdR is expressed in the forespore (Figure 6), on sporulation. 
The ACE methodology (Ng et al., 2013) was used to inactivate the tcdR gene. An 
allele exchange cassette was assembled composed of a left-hand homology arm (LHA) 
and a right-hand homology arm (RHA) relative to tcdR.  The LHA (645 bp) was amplified 
by PCR using primers tcdR-AscI-Fw and tcdR-SOE-Rev (bases 785966 to 786598 on the 
forward strand of the C. difficile 630Δerm genome; Appendix 4). The RHA (555 bp, 
which includes the first 184 bp of tcdB) was amplified by PCR using primers tcdR-SOE-
Fw and tcdR-SbfI-Rev (bases 787055 to 787576 on the forward strand of the C. difficile 
630Δerm genome; Appendix 4). The two fragments were joined by splicing by overlap 
extension (SOE) PCR and cloned between the AscI and SbfI sites of pMTL-YN3 (Ng et 
al., 2013) to produce pSR3 (Appendix 5). The fusion of the LHA with the RHA creates 
an in-frame deletion removing codons 27 to 178 of tcdR gene. 
pSR3 was introduced in C. difficile 630ΔermΔpyrE (Appendix 2) by conjugation. The 
transconjugants obtained were restreaked two times in BHIS with thiamphenicol and 
cefoxitin to select for the single crossover. Large colonies were tested for pure single 
crossovers clones by PCR using two pairs of primers (Figure 7): pair 1 tcdR-vef-Fw (P3) 
and YN3-vef-Fw (P2), and pair 2 tcdR-vef-Rev (P4) and YN3-vef-Rev (P1). Depending 
which homology arm undergoes recombination, the PCR’s from the single crossovers 
will result with pair 1 in 1665 bp and pair 2 in 2014 bp fragments, or with pair 1 in 2121 
bp and pair 2 in 1558 bp fragments (Figure 7A). Two colonies were shown by PCR to be 
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pure single crossovers (colonies 6 and 9; Figure 7B); colony 9 was selected to proceed 



















Next, single colonies were re-streaked onto minimal medium supplemented with FOA 
and uracil to select for cells in which the integrated plasmid had excised. Depending 
which homology arm undergoes recombination, plasmid excision can result in either the 
desired double crossover mutant, or a wild type cell (Figure 8). The isolated FOA resistant 
colonies were then screened by PCR using primers tcdR-vef-Fw and tcdR-vef-Rev that 
anneal to the upstream and the downstream sequence of tcdR, respectively (Figure 8A). 
Of the 18 colonies screened, 11 yielded the expected 1901 bp DNA fragment, indicative 
Figure 7 - ACE mutagenesis of the tcdR gene in the 630ΔermΔpyrE strain. A: In this simplified figure, pSR3 is 
composed by a left homology arm (LHA), the truncated gene previously amplified by SOE-PCR (ΔtcdR), a right 
homology arm (RHA) and the pyrE gene. These left and right homology arms are chromosome homology regions that 
will allow recombination and plasmid integration. This plasmid can integrate in two different ways which can be 
distinguish using P3 and P2 primers in a PCR reaction and P1 and P4 in another; B: Single cross-over analysis for 
tcdR mutagenesis. P3: tcdR-vef-Fw; P2: YN3-vef-Fw; P1: YN3-vef-Rev; P4: tcdR-vef-Rev. 1 to 12: tested clones. L: 
1 Kb Plus DNA ladder. These results show that there are two clones (6 and 9) that have the integrated pSR3. Regarding 
figure A, both clones integrated the plasmid as shown in the second option, since they presented PCR products with 
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of an in-frame deletion (Figure 8B). The other colonies yielded a 2357 bp DNA fragment, 
consistent with the presence of a wild-type copy of the gene (Figure 8B). Colony 1 was 
chosen for the further studies (630ΔermΔpyrEΔtcdR; Appendix 2). Colony 5 seemed to 
have both fragments, which probably mean that two colonies, instead of one, were used 

















On the isolated tcdR mutant, the pyrE− gene was converted back to pyrE+ using 
plasmid pMTL-YN1 (Ng et al., 2013) as described in the material and methods section. 
The presence of the wild type pyrE gene was confirmed by PCR using primers pyrE-vef-
Fw and pyrE-vef-Rev that anneal to the upstream and the downstream sequence of pyrE, 
respectively (Figure 9A). Using these primers, the strain 630ΔermΔpyrEΔtcdR should 
give rise to a PCR fragment of 7056 bp, caused by the insertion of the Lambda phage 6.5 
Kb in the pyrE locus (Heap et al., 2012; Figure 9A). All the colonies tested were positives 
for pyrE reversion, since they generated a PCR fragment of 664 bp equal to the one 
Figure 8 - ACE mutagenesis of tcdR gene in the 630ΔermΔpyrE strain. A: The goal of this mutagenesis is to replace 
the wild type gene by the truncated version. After integration, plasmid excision could leave the truncated gene in the 
chromosome or the wild type gene. The only way to distinguish between the two possibilities is to run a PCR using 
P3 and P4 primers. Chr, chromosome; B: Double cross-over mutant verification. P3: tcdR-vef-Fw; P4: tcdR-vef-Rev. 
1 – 18: tested clones. L: 1 Kb Plus DNA ladder. The wild type gene has 2357 bp while the mutated one has 1901 bp. 
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obtained using DNA from strain 630Δerm (Figure 9B). Colony 1 was selected to the 
further studies (630ΔermΔtcdR; Appendix 2).  
 
 
Since our original strain 630ΔermΔpyrEΔtcdR also has a specific in-frame deletion of 
the pyrE locus, ACE can be used to introduce a wild type copy of the tcdR gene into the 
chromosome at the pyrE locus concomitant with the correction of this allele back to the 
WT (PyrE+ phenotype). To complement the tcdR mutation the coding sequence of tcdR 
and its expected promoter region was amplified by PCR using primers tcdR-comp-
BamHI-Fw and tcdR-comp-HindIII-Rev (Appendix 4). The resulting 1479 bp fragment 
Figure 9 - pyrE reversion using the ACE system. A: In this case, reversion of the pyrE- allele to the WT is seeked 
in  the 630ΔermΔpyrEΔtcdR strain. The pMTL-YN1 has the wild type pyrE and a right homology arm (RHA). The 
goal is to integrate the plasmid and then excise it leaving in the chromosome the wild type pyrE. Only one of the four 
options fit the requirements. To confirm that the pyrE was reverted, P5 and P6 are used in a PCR reaction. Chr: 
Chromosome; B: pyrE reversion analysis. P5: pyrE-vef-Fw; P6: pyrE-vef-Rev. 1-4: tested clones. L: 1 Kb Plus DNA 
ladder. All the tested clones were pyrE revertants since the fragment size is the same as the one from the WT (630Δerm) 
strain (664 bp). There is no amplification of the 630ΔermΔpyrE strain because the pyrE gene is interrupted by the 
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(bases 785783 to 787243 on the forward strand of C. difficile 630Δerm genome) was 
digested with BamHI and HindIII and cloned in pMTL-YN1C (Ng et al., 2013) digested 
with the same enzymes, to create pSR5 (Appendix 5). pSR5 was transferred to the 
630ΔermΔpyrEΔtcdR strain by conjugation. Transconjugants were selected on minimal 
medium plates. Three independent PyrE+ clones able to grow on minimal medium, in the 
absence of uracil, were screened for the presence of the wild type allele by PCR, using 
primers pyrE-vef-Fw and pyrE-vef-Rev (Figure 10A). Only clones 2 and 3 gave the 
expected 2404 bp DNA product (Figure 10B). Clone 3 was the selected for further studies 
(630ΔermΔtcdR, pyrE::tcdR; Appendix 2). The strain with the in trans copy of tcdR at 
the pyrE locus will be referred to as ΔtcdRC for simplicity. 
Figure 10 - tcdR complementation using the ACE system. A: in trans complementation of the tcdR allele in the 
630ΔermΔpyrEΔtcdR strain. The pMTL-YN1C has the wild type pyrE, the wild type tcdR and a right homology arm 
(RHA). The goal is to integrate the plasmid at the pyrE locus and excise it, leaving in the chromosome the wild type 
pyrE and the functional tcdR. Only one of the four options fit in the requirements. Chr: Chromosome; B: tcdR 
complementation confirmation in the 630ΔermΔpyrEΔtcdR strain. P5: pyrE-vef-Fw; P6: pyrE-vef-Rev. 1-3: tested 
clones. L: 1 Kb Plus DNA ladder. If the gene was inserted in the pyrE locus as desired, the PCR fragment resulting 
from the pyrE verification primers would have 2404 bp; if not, the PCR reaction would produce a 664 bp fragment, 
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3.2. The tcdR mutation does not affect growth or sporulation 
To analyse the impact of the tcdR mutation on bacterial growth, the WT strain 
(630Δerm), the tcdR mutant, and the complementation strain were grown in TY and the 
optical density of the cultures was measured at 600 nm hourly until hour 12 after 
inoculation. As a control, the double ΔtcdAΔtcdB mutant was grown in parallel 
(630ΔermΔtcdAΔtcdB; Kuehne et al., 2010). All three strains, WT (630Δerm), ΔtcdR and 
the ΔtcdRC, have similar growth rates (0.5513 h-1, 0.5732 h-1 and 0.5527 h-1, respectively) 
and, about 8 hours after inoculation, they enter in stationary phase that is prolonged at 
least until hour 24 (Figure 11A). Therefore, deletion of tcdR has no impact on the growth 
rate of C. difficile at least under our culturing conditions. The double mutant ΔtcdAΔtcdB 
presented a lower growth rate when compared with the WT strain (0.4649 h-1 versus 
0.5513 h-1) and did not reach the same density as the other three strains. A similar 
observation was previously reported (Govind and Dupuy, 2012) and may be explained by 
cell lysis caused by the presence of TcdE (holin-like protein, see below) in the absence 
of the toxins. Since TcdR is the positive regulator of expression of the PaLoc, neither the 
toxin-encoding genes nor tcdE are expressed in the tcdR mutant. Perhaps for this reason, 













Figure 11 - Growth curves of the WT (630Δerm), ΔtcdR, ΔtcdRC and ΔtcdAΔtcdB strains. A: The OD of the 
cultures was measured at 600nm hourly until the 12th hour following inoculation and then, at hour 24. All strains 
presented similar growth rates and, with the exception of the ΔtcdAΔtcdB mutant, they all reached similar maximum 
OD levels. The reason for the different behaviour observed for the double mutant remains to be elucidated (but see 
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Since previous work from the laboratory (Figure 6) showed that tcdR expression 
occurs mostly inside the forespore, it seemed possible that TcdR could have a role in 
sporulation. To understand if this was the case, the mutant and the respective 
complementation strain were analysed for their ability to form heat resistant spores. 
Strains were grown in SM, a medium in which we found sporulation to be more 
synchronized (Pereira et al., 2013), and 24, 48 and 72 hours after inoculation the titer of 
heat resistant spores/ml of culture was determined (see the material and method section). 
In line with earlier results (Pereira et al., 2013), the titer of spores for the WT strain 
increased from 6.8x105 spores/ml of culture at hour 24, to 1.8 x106 spores/ml at hour 48 
and 1.4x106  spores/ml at hour 72 (Table 1). As expected from previous results (see 
above), the tcdR mutation did not affect cell viability (Table 1). Moreover, the titer of 
spores in the tcdR mutant was similar to the titer of WT spores, 2.3x106, 5.4x106 and 
4.4x106 spores/ml at hour 24, 48 and 72, respectively (Table 1). 
 
Table 1 - Sporulation efficiency of the tcdR mutant and complementation strain, in comparison to the WT, 24, 
48 and 72 hours following inoculation into SM. The analysis is based on the cfu/ml that are generated before and 
after treatment at 60ºC. The results are from a representative experiment; the standard deviation is also presented and 
results from three technical replicates.  













WT 1.8x108 ± 9.4x107 6.8x105 ± 2.4x105 2.5x107 ± 9x106 1.8x106 ± 5.3x105 3.4x107± 6,2x106 1.4x106 ± 5.7x105 
ΔtcdR 1.1x108 ± 4x107 2.3x106 ± 1.2x106 3.2x107 ± 7x106 5.4x106 ± 9.2x105 2.9x107 ± 6x106 4.4x106 ± 9x105 
ΔtcdRC 1.1x108 ± 8.1x106 8.4x105 ± 2.8x105 4.6x107 ± 9.1x106 1,2x106 ± 1.9x105 2.4x107 ± 5x106 1.2x106 ± 3.2x105 
 
Together these results show that the absence of the main positive regulator of 
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3.3. The role of TcdR in expression of the PaLoc genes 
To study the role of tcdR as the regulator of the PaLoc expression at the single cell 
level, we used the SNAPCd-tag system. With that purpose, the tcdR mutant and the 
complementation strain were conjugated with plasmids containing the tcdR or tcdA 
promoter regions fused to the SNAPCd-tag (Appendix 2). These two promoters were 
chosen to investigate the role of TcdR on expression of the gene coding for toxin A (NB: 
previous work has shown that the signal obtained from PtcdB-SNAPCd is very weak) as 
well as the auto-regulation of tcdR expression. Strains were grown in TY for 24 hours, 
labelled with the SNAPCd-tag substrate TMR-Star and imaged by fluorescence 
microscopy. 
As previously observed (Figure 6), expression of PtcdR-SNAPCd is detected in 5.8% of 
the vegetative cells of the wild type and in 32% of the sporulating cells, of which 31.7% 
show forespore-specific expression (Figure 12A and B). The tcdR mutant shows 
forespores-specific expression in 36.1% of the sporulating cells, and the complementation 
strains shows forespore-specific expression of PtcdR-SNAPCd in 30.4% of the sporulating 
cells. A quantitative analysis of the fluorescence signal per cell shows similar levels of 
fluorescence in individual cells of the three strains (Figure 12C). In contrast, the 
population of cells showing fluorescence in vegetative cells of the tcdR mutant and the 
complementation strain is slightly decreased (Figure 12B) when compared to the WT (0.6 
% for the mutant and 0.5 % for the complementation strain). However, the quantitative 
analysis of the individual cells showing a fluorescence signal shows similar levels of 
intensity (Figure 12C).  
We conclude that deletion of tcdR does not significantly curtail expression from its 
own promoter. Our results point for a minor role of the postulated positive auto-feedback 
loop of tcdR (Mani et al., 2002).  
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In agreement with previous results of the laboratory (Figure 6), expression of PtcdA-
SNAPCd is detected in 76% of the vegetative cells and in 78.8% of the sporulating cells 
for the WT (Figure 13A and B). In sporulating cells, two patterns of PtcdA-SNAPCd 
expression were seen: in one, the fusion was expressed only in the forespore in 0.17% of 
the sporulating cells; a second pattern corresponded to sporangia in which expression of 
the fusion was detected in both the mother cell and the forespore (78.6% of the sporulating 
cells). PtcdA-SNAPCd expression is not detected in any of the cell populations in the tcdR 
mutant (Figure 13). In contrast, in the complementation strain, the number of cells 
showing fluorescence and the fluorescence intensity per cell was restored to nearly WT 
levels (Figure 13C): 75.6% of the vegetative cells, 0.47% in the forespore, and 92.2% in 
whole sporangia. Thus, the tcdR copy present at the pyrE locus restored PtcdA-SNAPCd 
expression to the tcdR mutant. The phenotype of the mutant is thus due to loss of function 
of the tcdR gene.  
Figure 12 - TcdR is not essential for tcdR transcription. A: Fluorescence microscopy results for the WT (630Δerm), 
the ΔtcdR and the ΔtcdRC strains. These strains have a replicative plasmid with the tcdR promoter fused to the SNAPCd-
tag. The cells were labelled with the red TMR substrate (benzylguanine derivative coupled to the tetramethylrodamine 
fluorophore). C. difficile cells show green auto-fluorescence. The overlay corresponds to the auto-fluorescence and 
TMR images. Phase contrast (PC) images are also shown. Scale bar: 1 µm; B: Cells counting from the microscopy 
results. These values are separated in vegetative cells (with low and high signal) and sporulating cells (with signal in 
whole cell or only in the forespore); C: Quantification of the signal (Average fluorescence intensity in arbitrary units, 
or AU) in vegetative cells and inside the forespore at initial sporulation stages (from septum formation to phase dark 
spores development). The WT is represented by the blue dots, the ΔtcdR mutant by the orange dots and the 
complemented strain by the grey dots. 
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Together, the results confirm the requirement of TcdR for toxin production (or at least 
expression of the tcdA gene), but a minor role in the control of its own expression.  
 
3.4. TcdA accumulates at the surface of spores  
We found tcdR and tcdA to be expressed in the forespore, and we therefore anticipated 
accumulation of toxin A (TcdA) in the developing spore. Since the spore is hard to break, 
spore-specific expression of the toxin may have been missed until now. In order to further 
investigate association of TcdA with spores, we purified spores from the WT, the ΔtcdR 
mutant, the ΔtcdRC strain, and from the ΔtcdAΔtcdB mutant. Then, the coat proteins were 
extracted (coat fraction), and the decoated spores were submitted to lysozyme treatment. 
This treatment is thought to digest the exposed cortex releasing cortex-associated proteins 
(cortex fraction). Proteins from these fractions were resolved by SDS-PAGE and analysed 
by immunoblot using an anti-TcdA antibody (Figure 14). 
Figure 13 - TcdR protein is necessary for tcdA transcription. A: Fluorescence microscopy analysis of the WT 
(630Δerm), the ΔtcdR and the ΔtcdRC strains, bearing a replicative plasmid with the tcdA promoter fused to the 
SNAPCd-tag. The cells were labelled with the red SNAPCd substrate TMR-Star. Note that no signal is detected in the 
tcdR mutant. C. difficile cells show green auto-fluorescence. The overlay corresponds to the autofluorescence and 
TMR images. Phase contrast (PC) images are also shown. Scale bar: 1 µm; B: Scoring of the cells according to the 
indicated classes: vegetative cells (with low and high signal) and sporulating cells (with signal in whole cell or only 
in the forespore); C: Quantification of the fluorescence signal (Average fluorescence intensity, in arbitrary units, or 
AU) in vegetative cells and in the mother cells. The WT is represented by the blue dots and the complemented strain 
by the grey dots. 
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The profile and amount of proteins visualized by the gel stained with the coomassie 
brilliant blue solution is very similar among all strains except for the double mutant 
(Figure 14A). This strain did not show a protein migrating below the 25 kDa marker 
(Figure 14A, red arrow). Mass spectrometry analysis indicated that this species 
corresponds to a Rubrerythrin family protein (Rbr_1) with 20 kDa. The dependency on 
ΔtcdAΔtcdB for assembly of the Rbr_1 protein was not investigated further.  
In spores from the WT strain, the TcdA toxin (308 kDa) was detected in both the spore 
coat and cortex fractions. As expected, no TcdA was detected in spores from the tcdR 
mutant or the ΔtcdAΔtcdB mutant. In the ΔtcdRC strain, TcdA is also detected in both the 
coat and cortex fractions of the mature spore, although at slightly lower levels as 
compared to the WT (Figure 14B). As an indication of the decoating efficiency, the coat 
protein CotD (20 kDa; Permpoonpattana et al., 2011) was present only in the coat fraction 
(Figure 14C). Presently, a protein to be used as a specific marker for the cortex fraction 
has not been identified. In any event, these results show that, at least, TcdA is associated 
with the surface of mature spores. 
Figure 14 - TcdA accumulates at the spore surface. A: SDS-PAGE gel stained with coomassie brilliant blue. Four 
strains are compared: ΔtcdAΔtcdB, WT (630Δerm), ΔtcdR and ΔtcdRC. The first four layers are coat protein extracts, 
whereas the last four lanes correspond to a cortex fraction (see text for details); B: Western blot analysis of the gel in 
A. The antibody was a mouse monoclonal anti-TcdA (from Santa Cruz Biotechnology); C: Reprobing of the membrane 
in B using a mouse polyclonal that recognizes the spore coat protein CotD (Permpoonpattana et al., 2011).  
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3.5. Construction and in trans complementation of an in-frame deletion mutant 
of tcdE 
A previous study developed a tcdE mutant using the Clostron system (Govind and 
Dupuy, 2012). However, because this technique generates insertional mutations, the 
expression of downstream genes, such as tcdA, may be affected. Therefore, to decrease 
the possibility of polar effects, we constructed a tcdE mutant using the ACE mutagenesis 
system (Ng et al., 2013). This mutant would allow us to investigate a possible function 
of TcdE on sporulation, since tcdE expression was detected inside the forespore in 
previous work of this laboratory (as detailed in the Introduction). 
The ACE methodology (Ng et al., 2013) was used to inactivate the tcdE gene. An 
allele exchange cassette was assembled composed of a left-hand homology arm (LHA) 
and a right-hand homology arm (RHA) relative to tcdE. The LHA (621 bp, which includes 
the last 386 bp of tcdB) was amplified by PCR using primers tcdE-AscI-Fw and tcdE-
SOE-Rev (bases 794105 to 794695 on the forward strand of C. difficile 630Δerm genome; 
Appendix 4). The RHA (590 bp) was amplified by PCR using primers tcdE-SOE-Fw and 
tcdE-SbfI-Rev (bases 795038 to 795615 on the forward strand of C. difficile 630Δerm 
genome; Appendix 4). The two fragments were joined by splicing by overlap extension 
(SOE) PCR and cloned between the AscI and SbfI sites of pMTL-YN3 (Ng et al., 2013) 
to produce pSR4 (Appendix 5). The fusion of the LHA with the RHA creates an in-frame 
deletion removing codons 28 to 141 of tcdE gene. 
pSR4 was introduced in C. difficile 630ΔermΔpyrE (Appendix 2) by conjugation. The 
transconjugants obtained were restreaked two times in BHIS with thiamphenicol and 
cefoxitin to select for the single crossover. Large colonies were tested for pure single 
crossovers clones by PCR using two pairs of primers (Figure 15): pair 1 tcdE-vef-Fw (P3) 
and YN3-vef-Fw (P2), and pair 2 tcdE-vef-Rev (P4) and YN3-vef-Rev (P1). Depending 
which homology arm undergoes recombination, the PCR’s from the single crossover will 
result with pair 1 in 1680 bp and pair 2 in 2022 bp fragments, or with pair 1 in 2049 bp 
and pair 2 in 1707 bp fragments (Figure 15A). Five colonies were shown by PCR to result 
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from single crossovers (colonies 2, 3, 4, 5 and 6; Figure 15B); colony 2 was selected to 
proceed with the mutagenesis. 
 
 
Single colonies were then re-streaked onto minimal medium supplemented with FOA 
and uracil to select for cells in which the integrated plasmid had excised. Depending 
which homology arm undergoes recombination, plasmid excision can result in either the 
desired double crossover mutant, or a wild type cell. The isolated FOA resistant colonies 
were then screened by PCR using primers tcdE-vef-Fw and tcdE-vef-Rev that anneal to 
the upstream and the downstream sequence of tcdE, respectively (Figure 15C). Of the 12 
colonies screened, 3 yielded the expected 2043 bp DNA fragment, indicative of an in-
frame deletion (2, 4 and 5; Figure 15D). The other colonies yielded a 2385 bp DNA 
fragment, consistent with the presence of a wild-type copy of the gene (Figure 15D). 
Colony 2 was chosen for further studies (630ΔermΔpyrEΔtcdE; Appendix 2). Colonies 6 
and 8 seemed to have both fragments, possibly because two colonies, instead of one, were 
used in the genomic DNA extraction, resulting in a mixed culture. 
Figure 15 - ACE mutagenesis of the tcdE gene in strain 630ΔermΔpyrE. A: pSR4 can integrate in two different 
ways (see Figure 7) which can be distinguish using P3 and P2 in a PCR reaction and P1 and P4 in another. Chr, 
chromosome; B: Single cross-over analysis for tcdE mutagenesis. P3: tcdE-vef-Fw; P2: YN3-vef-Fw; P1: YN3-vef-
Rev; P4: tcdE-vef-Rev. 1 to 10: tested clones. L: 1 Kb Plus DNA ladder. Clones number 2, 3, 4, 5 and 6 are positives 
since they presented the expected 1680 bp and 2022 bp fragments; C: The goal of this mutagenesis is to replace the 
wild type gene by the truncated version. After integration, plasmid excision could leave the truncated gene in the 
chromosome or the wild type gene (see Figure 8). The way to distinguish between the two possibilities is to run a PCR 
using P3 and P4 primers; D: Double cross-over mutant verification. P3: tcdE-vef-Fw; P4: tcdE-vef-Rev. 1-12: tested 
clones. L: 1 Kb Plus DNA ladder. Depending on the presence of the wild type gene or the truncated version, two 
fragment sizes are expected. The wild type gene has 2385 bp while the mutated one has 2043 bp. Therefore, from the 
12 clones, 3 have the ΔtcdE mutation. 
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On the isolate tcdE mutant, the pyrE− gene was converted back to pyrE+ using plasmid 
pMTL-YN1 (Ng et al., 2013) as described in the material and methods section. The 
presence of the wild-type pyrE gene was confirmed by PCR using primers pyrE-vef-Fw 
and pyrE-vef-Rev that anneal to the upstream and the downstream sequence of pyrE, 
respectively (Figure 16A). Using these primers, strain 630ΔermΔpyrEΔtcdE should give 
rise to a PCR fragment of 7056 bp, caused by the insertion of the Lambda phage 6.5 Kb 
in the pyrE locus (Heap et al., 2012; Figure 9A). All the colonies tested were positives 
for the pyrE reversion, since they generated a PCR fragment of 664 bp equal to the one 
obtaining using the 630Δerm strain (Figure 16B). Colony 1 was selected for further 












As explained before, we can use ACE to introduce a wild type copy of the tcdE gene 
into the chromosome at the inactivated pyrE locus concomitant with the correction of this 
allele back to a wild type pyrE gene (resulting in a PyrE+ phenotype). However, 
expression of tcdE from its own promoter using a multicopy plasmid was observed to be 
lethal to C. difficile (Govind and Dupuy, 2012) therefore, the anhydrotetracycline (ATc) 
inducible gene expression system was used to control the expression of tcdE. To 
complement the tcdE mutation, the coding sequence of tcdE together with the three 
Figure 16 - pyrE reversion using the ACE system (A) and in trans complementation of tcdE in strain 
630ΔermΔpyrEΔtcdE (C). A: The goal is to restore the WT pyrE allele in strain 630ΔermΔpyrEΔtcdE. To confirm 
that the WT pyrE allele was restored, P5 and P6 were used in a PCR reaction (see Figure 9). Chr, chromosome; B: 
pyrE reversion analysis. P5: pyrE-vef-Fw; P6: pyrE-vef-Rev. 1-3: tested clones. L: 1 Kb Plus DNA ladder. All the 
tested clones were pyrE revertants since the fragment size is the same as the one from the WT strain (664 bp); C: 
Schematic image of the in trans tcdE complementation at the pyrE locus. This was confirmed using P5 and P6 primers; 
D) in trans complementation of tcdE analysis. P5: pyrE-vef-Fw: P6: pyrE-vef-Rev. 1 – tested clone. L: 1 Kb Plus DNA 
ladder. If the gene was inserted at the pyrE locus as desired, the PCR fragment resulting from the pyrE primers would 
have 1990 bp; the WT fragment have 664 bp. 
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published Ribossome Binding Site’s (Govind and Dupuy, 2012) were amplified by PCR 
using primers tcdE-comp-SacI-Fw and tcdE-comp-BamHI-Rev (Appendix 4). The 
resulting 543 bp fragment (794591 to 795115 on the forward strand of C. difficile 
630Δerm genome) was digested with SacI and BamHI and cloned in pFT46 (Pereira et 
al., 2013; Appendix 5) cleaved with the same enzymes. Since this plasmid already carries 
the ATc-inducible promoter, the tcdE fragment was inserted downstream of it. The NheI 
and BamHI sites were used to clone all the fragment (tcdE under the control of the 
inducible promoter) in the pyrE locus of pMTL-YN1C (Ng et al., 2013), resulting in 
pSR6 (Appendix 5). 
pSR6 was transferred to 630ΔermΔpyrEΔtcdE by conjugation. Transconjugants were 
selected on minimal medium plates. PyrE+ clones able to grow on minimal media in the 
absence of uracil were screened for the presence of the wild type allele by PCR using 
primers pyrE-vef-Fw and pyrE-vef-Rev (Figure 16C). Clone 1 gave the expected 1990 
bp DNA product (Figure 16D). The strain bearing the tcdE-inducible allele at the pyrE 
locus will be referred to as ΔtcdEC (Appendix 2). 
 
3.6. The tcdE mutation does not affect growth or sporulation 
To analyse the impact of the tcdE mutation on the bacterial growth, the WT strain 
(630Δerm), the tcdE mutant, and the complementation strain were grown in TY and the 
OD600 measured at hourly intervals until hour 12 following inoculation (Figure 17A). 
Because the complementation of tcdE demands induction by anhydrotetracycline (ATc), 
all strains were tested with and without ATc. Previous studies suggested that 20 ng/ml of 
ATc were suitable for complementation of tcdE (Govind and Dupuy, 1012). In this work, 
ATc concentrations of 20 ng/ml and 20 µg/ml were used herein. The higher concentration 
used in this work (20 µg/ml) was an attempt to force high levels of expression of tcdE 
and possibly a more clear lysis phenotype. 
In the presence of 20 ng/ml of ATc, all the three strains, WT (630Δerm), ΔtcdE and 
the ΔtcdEC, had similar growth rates (0.5493 h-1, 0.5564 h-1 and 0.549 h-1, respectively; 
Figure 17B) as well as without induction (0.5513 h-1, 0.5413 h-1 and 0.5416 h-1, 
respectively; Figure 17B). After about 8 hours, the cells enter into stationary phase at very 
similar ODs (Figure 17A). Therefore, under these conditions, the tcdE mutation or the 
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In the presence of 20 µg/ml of ATc, growth was impaired for all three strains. 
Therefore, the lysis observed for the complemented strain cannot be directly attributed to 
increased expression of tcdE (Figure 17). 
Since previous work from the laboratory (Figure 6) showed that the tcdE expression 
occurs mostly inside the forespore, we considered the possibility that this gene could have 
a role in sporulation. To test this possibility, the ability of the mutant to form heat resistant 
spores was assessed. Strains were grown in SM and after 24, 48 and 72 hours after 
inoculation, the titer of heat resistant spores/ml of culture was determined as described in 
the material and method section. In line with earlier results (Pereira et al., 2013), the titer 
of spores for the wild type strain increased from 4.3x105 spores/ml of culture at hour 24, 
to 1.2x106 spores/ml at hour 48 and 1.7x106  spores/ml at hour 72 (Table 2). As expected 
from the previous results (Figure 17A) the tcdE mutation did not affect cell viability 
(Table 2). Moreover, the titer of spores in the tcdE mutant was similar to the titer of WT 
Figure 17 – Growth curves of the WT, ΔtcdE and ΔtcdEC strains. A: The OD was measured at 600 nm hourly until 
12 hours after inoculation and then, at hour 24. Strains were induced with the indicated concentrations of ATc at the 
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spores, 1.5x105, 5.6x105 and 9x105 spores/ml at hour 24, 48 and 72, respectively (Table 
2). 
 
Table 2 - Sporulation efficiency of tcdE mutant strain, in comparison to the WT, 24, 48 and 72 hours following 
inoculation into SM. This analysis is based on the cfu/ml that are obtained on plates before and after heat treatment. 
The results are from a representative experiment; the standard deviation results from three technical replicates.  













WT 1.3x108 ± 9.2x107 4.3x105 ± 2.1x105 5.6x107 ± 1x107 1.2x106 ± 4.9x105 2.6x107± 6,7x106 1.7x106 ± 5.2x105 
ΔtcdE 1.5x108 ± 3.9x107 1.5x105 ± 5.6x104 6.7x107 ± 2.2x107 5.6x105 ± 1.7x105 2.3x107 ± 3.5x106 9x105 ± 3.5x105 
 
Together, these results show that the absence of the holin-like protein, TcdE, does not 
affect growth or sporulation of C. difficile, in agreement with the results of a previous 
study (Olling et al., 2012). 
 
3.7. Absence of TcdE does not affect the release of TcdA from vegetative cells 
The function of TcdE is controversial. Olling et al. (2012) showed that growth, 
sporulation and release of TcdA and TcdB from C. difficile strain 630 were not affected 
by inactivation of the tcdE gene. However, Govind and Dupuy (2012) argued that TcdE, 
an apparent holin, is required for efficient toxin secretion by C. difficile, but that it does 
so without causing significant cell lysis or membrane damage usually associated with 
phage holins. Toxin A was detected in the supernatant of vegetative cells in a WT strain 
whereas in the tcdE::ermB mutant, constructed using the Clostron system (Govind and 
Dupuy, 2012), the toxin was retained inside the cells (Govind and Dupuy, 2012). We 
investigated toxin secretion using our in-frame deletion ΔtcdE mutant. 
After 4 hours of growth, tcdE expression in the complementation strain was induced 
for 2 hours with ATc (20 ng/ml).  In parallel, ATc was added to the WT strain and the 
tcdE mutant. At the end of the induction period the cells were collected by centrifugation, 
and the presence of TcdA was investigated in the cell sediment and in the supernatant by 
dot blot using an anti-TcdA antibody. In one set of experiments, we used exactly the same 
conditions as described by Govind and Dupuy: at hour 6 of growth, the cells were 
collected, and the presence of TcdA in the two fractions was investigated. We found a 
weak signal for TcdA in the supernatant of all strains, which was only slightly above 
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background levels (estimated in the tcdA/tcdB double mutant). Moreover, we found no 
differences in the signal observed in the supernatant or the cell sediment between the 
stains under analysis (Figure 18A). These results suggest that TcdE has no major role in 
TcdA secretion, at least at this stage of growth, and are not in line with the results from 
the Govind and Dupuy study (Govind and Dupuy, 2012). In a second set of experiments, 
we examined the presence of TcdA in the supertant and the cell sediment prepared from 
cultures of the WT, the ΔtcdE mutant, the ΔtcdEC strain and the double tcdA/tcdB mutant 
during entry into stationary phase, when transcription of tcdA and also of tcdB is known 
to increase (Hundsberger et al., 1997). Samples were collected from cultures of the 
various strains 12, 16 and 20 hours after inoculation, with ATc (20 ng/ml) added at hour 
10. The samples were fraccionated and 60 µg of total supernantant protein, and 10 µg of 
total cell sediment protein were analysed by dot blot. The results of this experiment is 
shown on Figure 18B; we found no difference in the level of TcdA in the supernatants 
and in the cell sediments prepared from the different strains at any of the time points 
tested. These results are in agreement with those of Olling and co-authors (Olling et al., 













Figure 18 - TcdE has no major role in TcdA secretion from vegetative cells. A: detection of TcdA by dot blot in 
the supernant and cell sediment prepared from cultures of the WT, ΔtcdE, ΔtcdEC and ΔtcdAΔtcdB strains 6 hours 
following inoculation (see text for details). B: Dot blot assay using the supernatant and sediments prepared from 
cultures of the same strains as in panel A, but sampled 12, 16 and 20 hours following innoculation. Samples collected 
at hour 6 (panel A) were induced with 20 ng/ml of ATc at the hour 4 of growth; for the cultures in B, samples induction 
was carried out at hour 10 of growth. The supernatant was concentrated while cells from the sediment were lysed. In 
B, 60 µg of total protein were applied to the membrane for the supernatant sample, and 10 µg were analysed for the 
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3.8. TcdE has no relevant role on the accumulation of TcdA in spores 
We found tcdE to be expressed in the forespore, and since earlier results from this 
work (Figure 14) showed TcdA accumulation in the spore, we considered the possibility 
that TcdE could have a role on the localization of TcdA. The coat proteins were extracted 
from purified spores (coat fraction), and the decoated spores were subject to a lysozyme 
treatment that digested the exposed cortex and is thought to release cortex-associated 
proteins (cortex fraction). Proteins from these fractions were resolved by SDS-PAGE and 
analysed by immunoblot using an anti-TcdA antibody (Figure 19).  
The profile and amount of proteins visualized by the gel stained with the coomassie 
brilliant blue solution was very similar between all strains (Figure 19A). This suggests 
that TcdE has no major role on the assembly of the spore coat. 
In spores from the WT strain, the TcdA toxin (308 kDa) was detected in both the spore 
coat and cortex fractions. As expected, no TcdA was detected in spores from the 
ΔtcdAΔtcdB mutant. The ΔtcdE mutant strain also presented TcdA in both the coat and 
cortex fractions, although the level of the toxin seemed slightly reduced (Figure 19B). 
Coat protein CotA (34 kDa; Permpoonpattana et al., 2011) was only detected in the coat 
fraction (Figure 19C). Presently, no protein is known that can be used as a specific marker 































We conclude that TcdE plays no major role in the accumulation or localization of 














Figure 19 - TcdE has no relevant role on the accumulation of TcdA in spores. A: SDS-PAGE gel stained with 
coomassie brilliant blue. Three strains are compared: ΔtcdAΔtcdB, WT (630Δerm) and ΔtcdE.The first three layers are 
coat extracts, whereas the last three lanes correspond to a cortex fraction (see text for details); B: Western blot analysis 
of the gel in A, using a mouse monoclonal anti-TcdA antibody (from Santa Cruz Biotechnology); C: Reprobing of the 
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4. Discussion and Conclusion 
 
Using the recently described ACE mutagenesis technique (Ng et al., 2013), we 
constructed two mutants, bearing in-frame deletion mutations of the tcdR or tcdE genes, 
and the corresponding in trans complementation strains. The ΔtcdR mutant was used to 
determine the impact of the mutation on expression of tcdR as well as the remaining 
PaLoc genes, during vegetative growth and during sporulation. The ΔtcdE mutant was 
constructed to assess the contribution of the tcdE gene for the release of the toxins from 
cells during growth and during sporulation, as well as its possible contribution for the 
localization of the toxins in mature spores.  
The mutations did not affect the growth rate of the mutants, which suggests that neither 
TcdR nor TcdE are involved in cell viability (Figure 11 and 17). Moreover, no significant 
differences in the capacity to form spores were seen for the mutant strains in comparison 
to the WT (Table 1 and 2).  
In a previous study, Govind and Dupuy have shown that a ΔtcdAΔtcdB double mutant 
showed increased cell lysis during the transition to the stationary phase of growth as 
compared to the parental strain or PaLoc-negative strains (Govind and Dupuy, 2012). 
This effect was attributed to a possible role of the toxins in plugging the TcdE pore 
(Govind and Dupuy, 2012). We have also seen earlier lysis for the ΔtcdAΔtcdB mutant in 
the background of strain 630∆erm (Figure 11). In contrast, the ΔtcdR mutant, which does 
not produce toxin A (Figure 13) neither probably, any of the other PaLoc-encoded 
proteins including TcdE (Mani et al., 2001), does not shows signs of lyse. These 
observations are consistent with the plugging model, which also suggests that a pore 
formed by TcdE is the key mechanism involved in the release of the toxins from the cells 
(Govind and Dupuy, 2012). However, complementation of the tcdA and tcdB mutations 
in trans was not reported in the study of Govind and Dupuy (Govind and Dupuy, 2012). 
A clean genetic demonstration of the plugging model would involve expression of tcdE 
and tcdA/tcdB under the control of different inducible promoters, so that lysis, in case the 
model is correct, would only occur when only tcdE is induced. Transplantation of the 
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Previous work from our laboratory showed that the tcdR gene is transcribed in a 
fraction of vegetative cells, but also in sporulating cells (Figure 6). This important 
observation strongly suggests that the toxins are released from vegetative cells, at the 
onset of stationary phase, but accumulate in or associate with the developing spore. In 
any event, this observation shows a link between the processes of toxin production and 
spore differentiation.    
In vitro studies suggest that expression of tcdR is under positive auto-regulation (Mani 
et al., 2002): the regulatory region of the tcdR gene contains two promoters that are 
utilized by TcdR-containing RNA polymerase in vitro. An important question we 
addressed was whether auto-regulation of tcdR expression was important in vivo, in either 
vegetative or sporulating cells. If tcdR expression was under strong positive auto-
regulation, we expected the ΔtcdR mutation to severely curtail transcription of a PtcdR-
SNAPCd fusion. Strong positive auto-regulation can lead to the bifurcation of the 
population into two sub-populations, one above and the other below the threshold for 
auto-activation (Alon, 2007). Strong positive auto-regulation of tcdR expression in 
vegetative cells was expected because the preliminary results in the group showed that 
some cells expressed tcdR while other did not (see the Introduction; see also Figure 6).  
However, our results indicate that TcdR plays no relevant role in the expression of 
tcdR in either vegetative or sporulating cells at least under our culturing conditions 
(Figure 12). Presumably then, another factor is responsible for the observed bifurcation 
of the population with respect to tcdR expression. The answer may be in a third potential 
promoter located in the tcdR regulatory region, which is SigD-dependent. SigD is a sigma 
factor required for assembly of the flagellum and for motility and is thought to positively 
control toxin gene expression in vegetative cells by directly activating transcription of 
tcdR (El Meouche et al., 2013; Figure 20). Other results from the laboratory indicate that 
deletion of sigD as well as point mutation in the -10 element of the SigD-dependent 
promoter, significantly reduced expression of tcdR or tcdA in vegetative cells. SigD is not 
directly involved in sporulation (El Meouche et al., 2013) and accordingly, deletion of 
sigD did not eliminate forespore-specific expression of tcdR. However, we hypothesized 
that the SigD dependent promoter could also be utilized by regulatory proteins specific 
to the forespore. This appears to be the case, in fact, because point mutations in the -10 
region of the SigD-dependent promoter eliminated forespore-specific expression of tcdR 
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in the forespore. The SigD-dependent promoter may be utilized by SigG with the help of 
SpoVT, because: i) in E. coli, it is only when the two proteins are co-produced that a 
reporter for tcdR expression is produced; ii) production of the reporter is not detected 
when SigG and SpoVT are co-produced but expression of tcdR is under the control of the 
mutant SigD-type promoter. SigG together with the ancillary transcription factor SpoVT 
appear to ensure robust expression of tcdR in the forespore; tcdR expression was detected 
mostly in the forespore (Figure 12). Production of SpoVT is under the control of SigG 
(Saujet et al., 2013). Therefore, SigG and SpoVT define a coherent feed-forward loop 
(FFL) with AND gate logic that controls the expression of tcdR in the forespore. This 
circuit may have two consequences for production of TcdR in the forespore. First, 
production of TcdR may rely on signals that control the production and the activity of 
both SigG and SpoVT. For SigG, morphological signals may be involved, as the activity 
of SigG increases following engulfment completion (Pereira et al., 2013). The signals, if 
any, that control the activity of SpoVT, are not known. However, we note that the protein 
has a GAF domain, and may thus bind small molecules, including amino acids (Dong et 
al., 2004; Asen et al., 2009). Secondly, since activation of tcdR transcription depends on 
the accumulation of SpoVT above a certain threshold level, the FFL acts to delay the 
expression of the PaLoc in the forespore. Toxin production has a high energy cost 
(Aktories et al., 2000). We hypothesize that in this manner, the cost associated with the 










Figure 20 – Regulatory circuits governing tcdR expression. A: SigD is thought to positively control toxin gene 
expression in vegetative cells by directly activating transcription of tcdR (El Meouche et al., 2013); B: In the forespore, 
SigG and SpoVT probably define a coherent feed-forward loop (FFL) with AND gate logic that controls the expression 
of tcdR. No contribution of auto-regulation for tcdR expression under our conditions was detected.  
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While TcdR appeared essential for the expression of tcdA (Figure 13), most of the tcdR 
signal was confined to the forespore, whereas most of the tcdA signal was detected in 
vegetative and in the mother cell of sporulating cells (Figures 12 and 13). One possible 
explanation for this discrepancy may be that low expression of tcdR, difficult to detect 
and quantify under our experimental conditions, is sufficient for activation of tcdA 
transcription. In C. botulinum expression of botR, coding for an alternative RNA 
polymerase sigma factor required for expression of the gene, botA, coding for the 
botulinum neurotoxin A, was about 100-fold less than that of the botA gene (Couesnon et 
al., 2006). Thus, it appears possible that low levels of expression of the gene coding for 
the regulators of toxin expression are sufficient to generate high levels of expression of 
the toxin genes also in C. difficile.  
However, and as discussed above, the different levels of tcdR expression in vegetative 
cells may also be part of the reason why some vegetative cells show high expression of 
tcdA while other show low levels of tcdA transcription.  
Expression of tcdA is also detected in the mother cell of sporulating cells. Deletion of 
sigD eliminates this population (unpublished results of the laboratory), suggesting that 
some SigD remains active in the mother cell following asymmetric division. However, 
expression of tcdA in the forespore, was strictly dependent on tcdR, and on the forespore-
specific production of SigG and SpoVT (Figure 20).  
Complementation of the tcdR mutation in single copy at the pyrE locus almost totally 
restored the phenotype of the WT (Figures 12, 13 and 14). The small differences noticed 
may perhaps result from the absence of important sequences upstream or downstream of 
the tcdR fragment used for complementation. While further work is required to 
investigate this point, the overall conclusion of the complementation experiments is that 
the phenotype detected at the level of tcdA expression can be attributed mainly, if not 
exclusively, to the absence of TcdR. 
We assume that the conclusions relative to the expression of tcdA at the single cell 
level can be extended to tcdB. However we note that the level of expression of tcdB was 
much lower than that of tcdA. This precluded a detailed analysis of tcdB expression in 
vegetative as well as in sporulating cells.  
The forespore-specific expression of tcdA may result in the accumulation of TcdA in 
the forespore, and the rapid release of at least some TcdA during spore germination. This 
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may be an advantage during infection; low levels of toxin can trigger inflammation, which 
in turn promotes colonization. Release of the toxin during spore germination could 
rapidly provide sufficient toxins to promoter efficient colonization by the cell resulting 
from spore germination, which would not have to wait for toxin production and secretion 
(Figure 21; see also below). It will be interesting to determine whether TcdA is released, 
following spore germination, from outgrowing cells. 
An important discovery was the association of TcdA with the spore. In strain 
630∆erm, TcdA was found mainly associated with the spore coat, although some toxin 
was also found in a cortex fraction (Figure 14). The association of TcdA with the spore 
surface layers implies that the infectious spore already carries the toxin. This was the first 
time that C. difficile toxins were shown to associate with mature spores, more specifically 
with the surface layers of the spore. In C. perfringens the spore forming and the toxin 
producing cells also overlap, but enterotoxin production may be under the control of 
mother cell-specific regulatory proteins (Ohtani et al., 2013). Ungerminated B. anthracis 
spores also contained a detectable level of toxin components (Cote et al., 2005). It will 
be of pivotal importance to understand the biological relevance of a spore packed with 
toxins during the infectious cycle of C. difficile. One possibility is that the localization of 
TcdA at the surface of spores is required for efficient binding of the spore to the colonic 
mucosa, possibly to the same receptor recognized by TcdA. It is also possible that the 
toxin, partially exposed at the spore surface, is important to trigger inflammation, and 
facilitate colonization (see also preceding section). In any event, the levels and exact 
location of the TcdA in spores vary among epidemic strains, helping to explain their 
epidemiological profile. Further studies are required to test these ideas. 
The finding that TcdA is associated with the coat and cortex of mature spores raises 
the question of how it gets there. One possibility is that the TcdA is produced in the 
mother cell, at least in some of the sporulating cells, and it is recruited to the spore surface 
during the assembly of the spore cortex and coat sub-structures (Figure 21A). However, 
a different possibility is that the forespore-specific expression of tcdA also leads to the 
accumulation of TcdA at the spore surface. In this case, the implication would be that 
some of the toxin would have to be transported to the spore surface. In this scenario, we 
speculated that, perhaps, TcdE could be involved in the relocation of TcdA to the spore 
55 
 
Exploring the relationship between toxin and spore production             S. Ramalhete 
surface (Figure 21B). However, accumulation of TcdA and its localization in mature 







Previous work suggests a key role for TcdE in the release of TcdA and TcdB from C. 
difficile cells (Govind and Dupuy, 2012). We investigated whether we could reproduce 
this observation using our tcdE in-frame deletion mutant resulting from the ACE 
mutagenesis. However, we found no differences between the mutant strain ΔtcdE and the 
WT in what concerns the level of TcdA in the supernatant or cell-associated, at different 
stages of growth or sporulation. Thus, our results seem more consistent with other studies, 
in which TcdE was found not to have an impact on toxins release from the cells (Olling 
et al., 2012). While the role of TcdE in expression of the virulence phenotype remains 
unclear, an experiment that could be informative is to test for a role of TcdE in TcdA 
release from outgrowing cells, resulting from spore germination.  
The relationship between spore formation and toxin production by Clostridium 
difficile is essential to understand the infectious process and the epidemiological profile 










Figure 21 – Two posssible mechanisms for TcdA accumulation at the spore surface. A: TcdA is produced in the 
mother cell, at least in some of the sporangia cells, and it is recruited to the spore surface during the assembly of the 
spore cortex and coat sub-structures; and/or B: The forespore-specific expression of tcdA also leads to the 
accumulation of TcdA at the spore surface by an unknown mechanism. MC: Mother cell; FS: Forespore.  
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6. Appendix 
 














Strain Genotype Origin 
DH5α F– Φ80lacZΔM15 Δ(lacZYAargF) U169 recA1 endA1 hsdR17 
(rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 
Bethesda Research 
laboratories 
HB101 supE44 aa14 galK2 lacY1 D(gpt-proA) 62 rpsL20 (StrR) xyl-5 
mtl-1 recA13 D(mcrC-mrr) hsdSB(rB-mB-) RP4 
El Meouche et al., 
2013 
AHCD125 HB101 (pRP4) (pMS464) Laboratory stock 
AHCD144 HB101 (pRP4) (pMS470) " 
AHCD203 HB101 (pRP4) (pMTL-YN1) Ng et al., 2013 
AHCD204 HB101 (pRP4) (pMTL-YN1C) Ng et al., 2013  
AHCD207 HB101 (pRP4) (pMTL-YN3) Ng et al., 2013 
AHCD226 DH5α (pSR3) This work 
AHCD234 DH5α (pSR4) " 
AHCD239 HB101 (pRP4) (pSR3) " 
AHCD240 HB101 (pRP4) (pSR4) " 
AHCD284 DH5α (pSR5) " 
AHCD285 HB101 (pRP4) (pSR5) " 
AHCD342 DH5α (pSR6) " 
AHCD343 HB101 (pRP4) (pSR6) " 
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Appendix 2: Clostridium difficile strains used in this work 
 
C - complemented strain 
   
Strain Genotype Origin 
AHCD531 630Δerm Hussain et al., 2005 
AHCD591 630ΔermΔtcdAΔtcdB Kuehne et al., 2010 
AHCD608 C. difficile 630Δerm (pMS464)  Laboratory stock 
AHCD668 C. difficile 630Δerm (pMS470) " 
AHCD772 630ΔermΔpyrE Heap et al., 2012. 
AHCD811 630ΔermΔpyrEΔtcdR This work 
AHCD820 630ΔermΔtcdR " 
AHCD827 630ΔermΔpyrEΔtcdE " 
AHCD828 630ΔermΔtcdRC  " 
AHCD833 630ΔermΔtcdE " 
AHCD840 C. difficile 630ΔermΔtcdR (pMS464) " 
AHCD841 C. difficile 630ΔermΔtcdR (pMS470) " 
AHCD845 C. difficile 630ΔermΔtcdRC (pMS464) " 
AHCD846 C. difficile 630ΔermΔtcdRC (pMS470) " 
AHCD872 630ΔermΔtcdEC " 
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Amino acids (5x) 
1 L 
 
Casamino acids 50 50 10 
L-tryptophan 2.5 2.5 0.5 




Na2HPO4 50 50 5 
NaHCO3 50 50 5 
KH2PO4 9 9 0.9 




D-Glucose 100 200 10 
Trace salts (50x) 
500 ml 
 
(NH4)2SO4 1 2.0 0.04 
CaCl2.2H2O 0.65 1.3 0.026 
MgCl2.6H2O 0.5 1.0 0.02 
MnCl2.4H2O 0.25 0.5 0.01 








D-biotin (1000x) 0.01 1 0.001 
Calcium-D-
panthothenate (1000x) 
0.01 1 0.001 
Pyridoxine (1000x) 0.01 1 0.001 
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Appendix 4: Primers used in the work 
Name Sequence (5’→3’) 
tcdE-AscI-Fw CCC CGG CGC GCC TTG ATG ATA TAA AAT ATT ATT TTG 
tcdE-SOE-Rev TTC CTT TAA TCT CTT AGG CAT ATT CAT AAC GCC TCC TAG 
tcdE-SOE-Fw CCT AAG AGA TTA AAG GAA AAA ATA GC 
tcdE-SbfI-Rev CCC CCC TGC AGG ACT CTT CTA TTA GAT AAG 
tcdE-vef-Fw CAG CAG AAG CAT ATA TAG G 
tcdE-vef-Rev  GAG AGT GCT CTA TTT CTG C 
tcdE-comp-SacI-Fw CCC GAG CTC CAATAA AAA GGT GGA CTA TGA TGA 
tcdE-comp-BamHI-Rev CCC GGA TCC TTA CTT TTC ATC CTT AGC 
tcdR-AscI-Fw CCC CGG CGC GCC ATT ATC TTA AGA GAG GAG 
tcdR-SOE-Rev CAT AAA TAA AAT TTC TTG CAA ATC ATC 
tcdR-SOE-Fw TTG CAA GAA ATT TTA TTT ATG GAA AAT TAT TTT AAC TTG 
tcdR-SbfI-Rev CCC CCC TGC AGG TAT CTA TAT AAA TAT CTG 
tcdR-vef-Fw GTA TCA TTT CAC GAA GAG G 
tcdR-vef-Rev GGG TCA TTT AAG TTT TCT C 
tcdR-comp-BamHI-Fw CCC GGA TCC TAA AAA TAT TTT GAT ATG 
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pMS464 Plasmid carrying the tcdR promoter fused to the SNAPCd-tag. Resistance to 
Thiamphenicol. 
pMS470 Plasmid carrying the tcdA promoter fused to the SNAPCd-tag Resistance to 
Thiamphenicol. 
pFT46 Plasmid carrying a Ptet-SNAPCd transcriptional fusion (Pereira et al., 2013). Resistance 
to Thiamphenicol. 
pMTL-YN3 Plasmid to construct mutants in C. difficile 630ΔermΔpyrE using the Allele 
Coupled Exchange mutagenesis (Ng et al., 2013). Resistance to Thiamphenicol. 
pMTL-YN1 Plasmid to revert the pyrE gene in C. difficile 630ΔermΔpyrE using the Allele 
Coupled Exchange mutagenesis (Ng et al., 2013). Resistance to Thiamphenicol. 
pMTL-YN1C Plasmid to complement in trans and revert the pyrE gene of C. difficile 
630ΔermΔpyrE using the Allele Coupled Exchange mutagenesis (Ng et al., 2013). 
Resistance to Thiamphenicol. 
pSR3 Plasmid used for the tcdR mutagenesis of 630ΔermΔpyrE strain. With origin in the 
pMTL-YN3. Resistance to Thiamphenicol. 
pSR4 Plasmid used for the tcdE mutagenesis of 630ΔermΔpyrE strain. With origin in the 
pMTL-YN3.  Resistance to Thiamphenicol. 
pSR5 Plasmid used to complement tcdR in trans and revert the pyrE gene of C. difficile 
630ΔermΔpyrEΔtcdR. With origin in the pMTL-YN1C. Resistance to 
Thiamphenicol. 
pSR6 Plasmid used to complement tcdE in trans and revert the pyrE gene of C. difficile 
630ΔermΔpyrEΔtcdE. With origin in the pMTL-YN1C. Resistance to 
Thiamphenicol. 
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